<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-11-03</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-11-03</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>77</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>5</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ“° å…¬ä¼—å·</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
ã€Šè‡ªç„¶ã€‹é‡å¤§çªç ´ï¼šé¦–æ¬¡æ¿€æ´»pMMRç»“è‚ ç™Œâ€œå†·è‚¿ç˜¤â€ï¼Œæ–°è¾…åŠ©å…ç–«æ²»ç–—è·æˆåŠŸã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- è§£æéå°ç»†èƒè‚ºç™Œæœ¯åå¤å‘æœºåˆ¶ã€‚<br />
- ç™Œç—‡ä¸­çš„è¡°è€æœºåˆ¶åŠçº¿ç²’ä½“è„‚è´¨ä»£è°¢åœ¨è‚¿ç˜¤å…ç–«ä¸­çš„ä½œç”¨ã€‚<br />
- AIåœ¨åŸºå› ç»„ç¼–è¾‘é¢†åŸŸçš„åº”ç”¨ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- æ•´åˆWESã€çº³ç±³å­”åŠscRNA-seqæŠ€æœ¯ã€‚<br />
- åŸºäºSignacè¿›è¡Œå•ç»†èƒçº¿ç²’ä½“DNAåˆ†å‹ä¸æŸ“è‰²è´¨å¯åŠæ€§è”åˆåˆ†æã€‚<br />
- EDASeqåŒ…å®ç°RNA-Seqè‡ªåŠ¨åŒ–åˆ†æã€‚<br />
- metaforåŒ…æä¾›é«˜çº§å…ƒåˆ†æå¯è§†åŒ–å·¥å…·ï¼ˆGOSHå›¾ï¼‰ã€‚<br />
- åˆ©ç”¨å¤šç»„å­¦è¯†åˆ«ä¸‰çº§æ·‹å·´ç»“æ„ï¼ˆTLSï¼‰å¹¶é¢„æµ‹é¢„ååŠå…ç–«æ²»ç–—ç–—æ•ˆã€‚</p>
<h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
äººè„å¸¦é—´å……è´¨å¹²ç»†èƒå¤–æ³Œä½“é€šè¿‡è°ƒæ§XBP1é€šè·¯ä¸Šçš„é’™ç¨³æ€ï¼Œä¿æŠ¤ç§»æ¤èƒ°å²›å…å—å†…è´¨ç½‘åº”æ¿€æŸä¼¤ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- æ¢ç´¢å¹²ç»†èƒå¤–æ³Œä½“åœ¨ç»„ç»‡ä¿®å¤ä¸å†ç”Ÿï¼ˆå¦‚èƒ°å²›ç§»æ¤ã€ç¥ç»é€€è¡Œæ€§ç–¾ç—…ï¼‰ä¸­çš„ä½œç”¨æœºåˆ¶ã€‚<br />
- è§£ææ¤ç‰©ï¼ˆå¦‚å¤§è±†ï¼‰ç§å­å‘è‚²è¿‡ç¨‹ä¸­çš„è½¬å½•ç»„ä¸ä»£è°¢ç»„æ™¯è§‚ï¼Œæ­ç¤ºè¥å…»ç§¯ç´¯çš„è°ƒæ§ç½‘ç»œã€‚<br />
- ç ”ç©¶è¡¨è§‚é—ä¼ è°ƒæ§å› å­ï¼ˆå¦‚MeCP2, YTHDF3, PRC1ï¼‰åœ¨å‘è‚²ã€ç–¾ç—…ï¼ˆå¦‚é£Ÿç®¡ç™Œã€ç¥ç»å‘è‚²ï¼‰ä¸­çš„è½¬å½•è°ƒæ§åŠŸèƒ½ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- ç»“åˆç©ºé—´è½¬å½•ç»„å­¦ä¸ä»£è°¢ç»„å­¦ï¼Œè§£æå‘è‚²è¿‡ç¨‹çš„ç©ºé—´å¼‚è´¨æ€§ã€‚<br />
- FIRESCAPEæŠ€æœ¯ç”¨äºè¿½è¸ªç»†èƒå¤–ç»„åˆ†ï¼ˆå¦‚ç»„è›‹ç™½H3ï¼‰çš„æ¸…é™¤ã€æŸä¼¤è¯±å¯¼åŠç»†èƒæ‘„å–æœºåˆ¶ã€‚</p>
<h3>ğŸ”¬ æœŸåˆŠæ–‡ç« </h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
äººå·¥æ™ºèƒ½ï¼ˆAIï¼‰æ­£å…¨é¢é©æ–°è‚¿ç˜¤å­¦ç ”ç©¶ï¼Œä»æœºåˆ¶é˜æ˜åˆ°ä¸ªæ€§åŒ–æ²»ç–—ï¼Œå±•ç°å¹¿é˜”å‰æ™¯ã€‚åŒæ—¶ï¼Œé¶å‘CDK12/13æˆ–RAS-GTPæŠ‘åˆ¶å‰‚ç­‰æ–°å‹ç­–ç•¥ï¼Œæœ‰æœ›å…‹æœKRASG12CæŠ‘åˆ¶å‰‚çš„è·å¾—æ€§è€è¯æ€§ï¼Œä¸ºéå°ç»†èƒè‚ºç™Œæ‚£è€…å¸¦æ¥çªç ´ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒï¼ˆTIMEï¼‰çš„é‡å¡‘ï¼Œèšç„¦ç»†èƒæ­»äº¡ï¼ˆç‰¹åˆ«æ˜¯å…ç–«åŸæ€§ç»†èƒæ­»äº¡ICDï¼‰ä¸å…ç–«æ¿€æ´»çš„ä¸²æ‰°ã€‚<br />
- æ¢ç´¢Iå‹å¹²æ‰°ç´ ä¿¡å·ä¼ å¯¼åœ¨è‚¿ç˜¤å…ç–«ç›‘æµ‹ä¸­çš„ä½œç”¨åŠå…¶èƒŒæ™¯ä¾èµ–æ€§ã€‚<br />
- è¯„ä¼°æ–°å‹å…ç–«ç–—æ³•ï¼ˆå¦‚Domvanalimabè”åˆzimberelimabï¼‰åœ¨ä¸Šå°¿è·¯ç™Œç—‡ä¸­çš„ç–—æ•ˆã€‚<br />
- æ·±å…¥ç ”ç©¶é¶å‘æ²»ç–—ï¼ˆå¦‚ç‹„è¯ºå¡éº¦ã€ctDNAæ£€æµ‹ï¼‰åœ¨éª¨è‚‰ç˜¤ã€ä¹³è…ºç™Œç­‰ç™Œç—‡ä¸­çš„åº”ç”¨åŠé¢„åé¢„æµ‹ã€‚<br />
- å…³æ³¨ç”Ÿæ´»æ–¹å¼ï¼ˆå¦‚èº«ä½“æ´»åŠ¨ï¼‰å¯¹æ¶ˆåŒ–ç³»ç»Ÿç™Œç—‡é£é™©å’Œæ­»äº¡ç‡çš„å½±å“ã€‚<br />
- æœºåˆ¶ç ”ç©¶ï¼šæ­ç¤ºå¾®å«æ˜Ÿç¨³å®šç»“ç›´è‚ ç™Œï¼ˆMSS CRCï¼‰é¶å‘æ²»ç–—åè·å¾—é«˜è‚¿ç˜¤çªå˜è´Ÿè·ï¼ˆTMBï¼‰åŠå¯¹å…ç–«æ²»ç–—çš„æ•æ„Ÿæ€§ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- <strong>AIèµ‹èƒ½è‚¿ç˜¤å­¦</strong>ï¼šæ•´åˆè®¡ç®—ç¡¬ä»¶ã€ç®—æ³•å¼€å‘åŠå¤šç»´åº¦ç™Œç—‡å¤§æ•°æ®ï¼ˆæˆåƒã€åŸºå› ç»„å­¦ã€ä¸´åºŠä¿¡æ¯ï¼‰ï¼Œæ¨åŠ¨AIåœ¨ç™Œç—‡ç ”ç©¶ä¸­çš„å¹¿æ³›åº”ç”¨ã€‚<br />
- <strong>å…‹æœè¯ç‰©è€è¯æ€§</strong>ï¼šé€šè¿‡é¶å‘CDK12/13æˆ–RAS-GTPæŠ‘åˆ¶å‰‚ï¼Œå…‹æœKRASG12CæŠ‘åˆ¶å‰‚åœ¨éå°ç»†èƒè‚ºç™Œä¸­çš„è·å¾—æ€§è€è¯ã€‚</p>
<h3>ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
H2O AutoML åœ¨é«˜æ³¢åŠ¨æ€§é‡‘èå¸‚åœºï¼ˆå¦‚ STOXX 600ï¼‰å®ç°é«˜æ€§èƒ½é¢„æµ‹ï¼Œä»¥åŠä¸€ç§æ–°çš„è¿‘ä¼¼è¯æ®æ–¹æ³•ï¼Œç”¨äºè¯„ä¼°2009å¹´æå‡ºçš„æ–¹æ³•ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- é‡‘èå¸‚åœºé«˜ç²¾åº¦é¢„æµ‹ï¼ˆSTOXX 600ï¼‰<br />
- æ•°æ®ç§‘å­¦æµæ°´çº¿æ„å»ºçš„è‡ªåŠ¨åŒ–<br />
- Rè¯­è¨€ä¸­å¤„ç†å¤æ‚ Shiny ç»„ä»¶çš„æµ‹è¯•</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- åˆ©ç”¨ H2O AutoML åº”å¯¹é‡‘èæ•°æ®çš„å™ªå£°å’Œéå¹³ç¨³æ€§ã€‚<br />
- æ”¹è¿› Shiny åº”ç”¨æµ‹è¯•æ–¹æ³•ï¼Œé€šè¿‡ JavaScript API ç®€åŒ–å¤æ‚ç»„ä»¶äº¤äº’ã€‚<br />
- æå‡ºä¸€ç§æ–°çš„è¿‘ä¼¼è¯æ®æ–¹æ³•ï¼Œç”¨äºè¯„ä¼°å·²æœ‰ç»Ÿè®¡æ¨¡å‹ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
ç©ºé—´å¤šç»„å­¦æ•°æ®æ•´åˆåˆ†ææ–°æ–¹æ³•MultiGATEï¼›å•ç»†èƒRNAæµ‹åºæ­ç¤ºè¡°è€å¯¹Tç»†èƒåŠŸèƒ½çš„å½±å“ï¼Œè§£é‡Šç–«è‹—å“åº”å‡å¼±æœºåˆ¶ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
*   <strong>å•ç»†èƒç»„å­¦</strong>ï¼šå¼€å‘è®¡ç®—å·¥å…·ï¼ˆSCSES, sysVI, CytoTRACE 2ï¼‰æå‡å•ç»†èƒRNAæµ‹åºæ•°æ®åˆ†æç²¾åº¦ã€æ•´åˆèƒ½åŠ›åŠå‘è‚²æ½œèƒ½é¢„æµ‹ï¼›æ¢ç´¢å•ç»†èƒRNAä¸ä»£è°¢ç‰©çš„åŒæ—¶åˆ†æã€‚<br />
*   <strong>ç™Œç—‡ç ”ç©¶</strong>ï¼šæ‰©å±•å„¿ç§‘ç™Œç—‡åŸºå› ç»„å­¦å’Œä¸´åºŠæ•°æ®å¼€æ”¾è·å–èµ„æºï¼ˆOpenPedCanï¼‰ã€‚<br />
*   <strong>ç»†èƒç”Ÿç‰©å­¦</strong>ï¼šå¼€å‘P-body-seqæŠ€æœ¯ï¼Œå…¨é¢åˆ†æPä½“ï¼ˆRNAè°ƒæ§çš„å…³é”®ç»“æ„ï¼‰æˆåˆ†ï¼Œæ­ç¤ºå¹²ç»†èƒåˆ†åŒ–æœºåˆ¶ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
*   <strong>æ–°å‹æ•´åˆåˆ†æ</strong>ï¼šMultiGATEåˆ©ç”¨å›¾è¡¨ç¤ºå­¦ä¹ æ•´åˆç©ºé—´å¤šç»„å­¦æ•°æ®ã€‚<br />
*   <strong>é¦–æ¬¡åŒæ­¥åˆ†æ</strong>ï¼šé¦–æ¬¡å®ç°å•æ ªæ¤ç‰©ç»†èƒä¸­åŸºå› è¡¨è¾¾ä¸ä»£è°¢ç‰©çš„åŒæ­¥æµ‹é‡ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“° å…¬ä¼—å· (13æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨13æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>Nature Commun | åŸºäº WESã€çº³ç±³å­”åŠ scRNA-seq çš„ I æœŸéå°ç»†èƒè‚ºç™Œæœ¯åå¤å‘æœºåˆ¶è§£æ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒå¤©åœ°<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€RNAseqã€scRNA<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI1Njk4ODE0MQ==&amp;mid=2247533437&amp;idx=1&amp;sn=e480626d1480fe25a4e5347cfa760c8f" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>ä¸€é”®å¯åŠ¨RNA-Seqåˆ†æï¼EDASeqåŒ…ï¼Œè®©åŸºå› æ•°æ®è‡ªå·±è¯´è¯ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šäº‘ç”Ÿä¿¡<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€RNAseqã€RåŒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg5MDk3Mzg4OA==&amp;mid=2247498382&amp;idx=1&amp;sn=02fbb95fc3156baa3eef649bba7b34f8" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>åŸºäºSignacçš„å•ç»†èƒçº¿ç²’ä½“DNAåˆ†å‹ä¸æŸ“è‰²è´¨å¯åŠæ€§è”åˆåˆ†æå­¦ä¹ </strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒå¤©åœ°<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€scDNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šä¸Šå‘¨å­¦ä¹ äº†åŸºäºSignacçš„scATAC-seqæµç¨‹å­¦ä¹ ï¼Œè¿™å‘¨å­¦ä¹ ä¸€ä¸‹å•ç»†èƒçº¿ç²’ä½“DNAåˆ†å‹ä¸æŸ“è‰²è´¨å¯åŠæ€§çš„è”åˆåˆ†æã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI1Njk4ODE0MQ==&amp;mid=2247533463&amp;idx=1&amp;sn=5e783f747366b4c5960b0cd3324462f1" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>åŸºäºSignacçš„å•ç»†èƒçº¿ç²’ä½“DNAåˆ†å‹ä¸æŸ“è‰²è´¨å¯åŠæ€§è”åˆåˆ†æå­¦ä¹ </strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡æ–¹èˆŸ<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€scDNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šä¸Šå‘¨å­¦ä¹ äº†åŸºäºSignacçš„scATAC-seqæµç¨‹å­¦ä¹ ï¼Œè¿™å‘¨å­¦ä¹ ä¸€ä¸‹å•ç»†èƒçº¿ç²’ä½“DNAåˆ†å‹ä¸æŸ“è‰²è´¨å¯åŠæ€§çš„<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkwMjYyMDA1OA==&amp;mid=2247489198&amp;idx=1&amp;sn=edaca45a1572467bd65df8f2adc1c787" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>ç»¼è¿° | Cancer Cell | ç™Œç—‡ä¸­çš„è¡°è€</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šBioJournal Link<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡ã€cancer<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg5NjgxNjkwOA==&amp;mid=2247502268&amp;idx=1&amp;sn=7e345d30661c7a5ef1b8d1138e430e30" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>metaforåŒ…: GOSH å›¾</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šR å­¦ä¹ è·µè¡Œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRåŒ…<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šGOSH å›¾æ˜¯ä¸€ç§é«˜çº§å…ƒåˆ†æå¯è§†åŒ–å·¥å…·ï¼Œé€šè¿‡å…¨å±€æˆ–éšæœºå­é›†çš„æ•ˆåº”ä¼°è®¡åˆ†å¸ƒæ­ç¤ºç ”ç©¶å¼‚è´¨æ€§ã€‚å®ƒèƒ½å¤Ÿï¼šå®šé‡è¯„ä¼°å¼‚è´¨æ€§ç›´è§‚æ˜¾ç¤ºå¼‚å¸¸ç‚¹å’Œæ½œåœ¨äºšç»„è¾…åŠ©å…ƒåˆ†æè´¨é‡æ§åˆ¶ä¸æ¨¡å‹è¯Šæ–­<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkzNzY2NDgyOQ==&amp;mid=2247493087&amp;idx=1&amp;sn=579ae48facf41f11c574dd61c5babef5" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>10+ç”Ÿä¿¡ï¼ŒåŸºäº Ro/e å‘ç°ä¸åŒæ²»ç–—ååº”æ‚£è€… CD8Teff ç»†èƒæ¯”ä¾‹å·®å¼‚ã€‚ç»†èƒä¸°åº¦åˆ†æè¯†åˆ«å…³é”®ç»†èƒç›®å‰åœ¨é«˜åˆ†æ–‡ç« ä¸­å¾ˆå¸¸è§ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šä¸œæ™“ç”Ÿç‰©<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç”Ÿä¿¡<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2OTU2MzM2NA==&amp;mid=2247492980&amp;idx=1&amp;sn=d19f6e9b5d3314cebce58081021ad6c1" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>æœ€æ–°8+ç”Ÿä¿¡ï¼Œå¤šç»„å­¦è¯†åˆ«ä¸‰çº§æ·‹å·´ç»“æ„ï¼ˆTLSï¼‰ç»“æ„å¹¶è¿›è¡Œé’ˆå¯¹æ€§åˆ†æã€‚é¢„æµ‹é¢„ååŠå…ç–«æ²»ç–—ç–—æ•ˆï¼Œå€¼å¾—å€Ÿé‰´ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503798&amp;idx=1&amp;sn=b3d9c811c01b5239d6adb16a0094e2c4" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>è½»æ¾ä¸€è¯» | 15åˆ†1åŒºçº¯ç”Ÿä¿¡ï¼Œæœºå™¨å­¦ä¹ ï¼šè¿™æ¬¡æˆ‘è¿ä»£ç éƒ½æ²¡å†™ï¼Œå°±ä¸Šäº†æ ‡é¢˜ï¼Ÿ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡ä½œæ›²å®¶<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šå½“ä¸€ç¯‡çº¯ç”Ÿä¿¡æ–‡ç« ï¼Œæ‹¥æœ‰äº†ä¸€ä¸ªâ€œAIç¾é¢œâ€çš„æ ‡é¢˜<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI5ODI0NzM2OQ==&amp;mid=2247491568&amp;idx=1&amp;sn=afca087bd6fd319c68dae62100c56a22" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>å®ç–åœ£/Ping-Chih Hoå›¢é˜ŸTREIMMç»¼è¿° | çº¿ç²’ä½“è„‚è´¨ä»£è°¢åœ¨è‚¿ç˜¤å…ç–«ç›‘è§†ä¸å…ç–«é€ƒé€¸ä¸­çš„å…³é”®ä½œç”¨</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šCellPresså…¨ç§‘å­¦<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šè¯¥æ–‡æ€»ç»“å’Œé˜è¿°äº†çº¿ç²’ä½“è„‚è´¨ä»£è°¢åœ¨è‚¿ç˜¤å…ç–«ç›‘è§†å’Œå…ç–«é€ƒé€¸ä¸­å‘æŒ¥çš„å…³é”®ä½œç”¨ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247656689&amp;idx=2&amp;sn=85e412a73c5415c1473c9e1cba425540" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>11.</strong> <strong>æ²³å—å†œä¸šå¤§å­¦é™ˆéœ‡/å§¬ç¥¥å›¢é˜ŸTrends in Biotechnologyç»¼è¿° | AIç‚¹äº®åŸºå› ç»„ç¼–è¾‘çš„æœªæ¥å›¾æ™¯</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šCellPresså…¨ç§‘å­¦<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šåŸºå› ç»„<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šè¯¥ç ”ç©¶ç³»ç»Ÿç»¼è¿°äº†æ·±åº¦å­¦ä¹ æŠ€æœ¯åœ¨åŸºå› ç»„ç¼–è¾‘é¢†åŸŸä¸­çš„åº”ç”¨ä¸å‘å±•ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247656689&amp;idx=1&amp;sn=c2238e7a0edb57d24efc1ef9820f978a" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>12.</strong> <strong>NPJ Precision Oncology | ä½ ä¸¢æ‰çš„å¢æ®–ç»†èƒï¼Œå¯èƒ½æ˜¯åŒºåˆ†è‚ºç™Œå…ç–«å’ŒåŒ–ç–—æ•æ„Ÿæ€§çš„å…³é”®ï¼Ÿ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å®åº“<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šoncology<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šè‚ºç™Œä½œä¸ºå…¨çƒç™Œç—‡ç›¸å…³æ­»äº¡æ’åç¬¬ä¸€çš„ç™Œå‹ï¼Œå…¶æœ€å¸¸è§çš„ç»„ç»‡å­¦äºšå‹â€”â€”è‚ºè…ºç™Œâ€”â€”æ„æˆäº†ä¸¥å³»çš„å…¬å…±å«ç”ŸæŒ‘æˆ˜ã€‚å°½ç®¡è¿‡å»å‡ åå¹´é—´ï¼Œåœ¨åŒ–å­¦ç–—æ³•ã€åˆ†å­é¶å‘æ²»ç–—ä»¥åŠè‚¿ç˜¤å…ç–«ç–—æ³•é¢†åŸŸå–å¾—äº†é•¿è¶³è¿›æ­¥ï¼Œä½†LUADæ‚£è€…çš„äº”å¹´æ€»ç”Ÿå­˜ç‡ä»å¾˜å¾Šåœ¨20%ä»¥ä¸‹ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI4MjY5ODI1Nw==&amp;mid=2247496426&amp;idx=1&amp;sn=05533e14b0fc941ae699f44df140860f" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>13.</strong> <strong>26%ï¼ã€Šè‡ªç„¶ã€‹é‡å¤§çªç ´ï¼špMMR ç»“è‚ ç™Œâ€œå†·è‚¿ç˜¤â€é¦–æ¬¡è¢«æ¿€æ´»ï¼Œæ–°è¾…åŠ©å…ç–«æ²»ç–—å¤§è·æˆåŠŸï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šCNSæ–‡çŒ®ç²¾è¯»ä¼š<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkzMzY5NDk3NA==&amp;mid=2247493129&amp;idx=1&amp;sn=5691d8b24e10e56d431439e3ccc09041" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (32æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰25æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE296373 äººè„å¸¦é—´å……è´¨å¹²ç»†èƒæ¥æºçš„ç»†èƒå¤–å›Šæ³¡é€šè¿‡è°ƒèŠ‚åŸºäº XBP1 çš„é’™ç¨³æ€æ¥ä¿æŠ¤ç§»æ¤çš„èƒ°å²›å…å—å†…è´¨ç½‘åº”æ¿€è¯±å¯¼çš„çº¿ç²’ä½“åŠŸèƒ½éšœç¢</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€carcinomaã€lymphomaã€Hi-Cã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€proteomicsã€metabolomeã€Bioconductorã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€clusteringã€resistanceã€depmap<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Baicheng Kuang ; Jimeng Ruan ; Hao Yan ; Shiqi Gu ; Tongwen Ou ; Nianqiao GongSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusIslet transplantation is an ideal option for diabetes while early graft lose serves as a major obstacle. Human umbilical cord mesenchymal stem cells (hucMSC) have multiple functions including the maintenance of cellular homeostasis. However, it is unknown whether extracellular vesicles (EVs) derived from hucMSC (hucMSC-EVs) provide protective effects against transplant-related trauma-induced islet injury. Here, we isolated and purified hucMSC-EVs, and found that hucMSC-EVs promoted grafted islet survival, and enhanced glycemic control following co-transplantation in a syngeneic streptozotocin (STZ)-induced mouse model of diabetes. After co-cultured for 12 h or 24 h, labelled hucMSC-EVs with PKH67 were readily internalized by NIT-1 Î² cells and islets. In tunicamycin (Tm) and thapsigargin (Tg) induced specific endoplasmic reticulum stress (ERS) cell injury models, hucMSC-EVs treatment improved cell viability and Î² cells function both in NIT-1 cells and ex vivo primary islets. Bulk RNA-seq demonstrated that hucMSC-EVs treatment significantly involved in ERS and the negative regulated mitochondrial apoptotic pathway. While ERS promoted interactions between endoplasmic reticulum (ER) and mitochondria, hucMSC-EVs alleviated ERS, maintained calcium homeostasis, and improved mitochondrial energy metabolism. Notably, the downregulation of XBP1 by hucMSC-EVs fine-tuned ER-mitochondria communication via reducing inositol-1,4,5-trisphosphate receptors at mitochondria-associated membranes (MAMs). Reduced XBP1 also activated Nrf2, restoring mitochondrial calcium homeostasis under ERS. miRNA analysis identified miR-182-5p enriched in hucMSC-EVs that specifically targeted XBP1 mRNA, leading to its degradation and downregulation. These findings demonstrate that hucMSC-EVs protect grafted islets by blocking XBP1 and restoring calcium homeostasis, thus suggesting their potential as a cell-free therapy for improving islet transplantation outcomes.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296373" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE281215 é‡ç”Ÿå¤§è±†ç§å­å‘è‚²çš„æ—¶ç©ºè½¬å½•ç»„å’Œä»£è°¢ç»„å›¾è°±æ­ç¤ºäº†è¥å…»ç§¯ç´¯çš„è°ƒæ§æœºåˆ¶ [scRNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€RNA-seqã€RNAseqã€DNA-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€spatial transcriptomicsã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€proteomicsã€metabolomeã€metabolomicsã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€enrichmentã€resistance<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Glycine sojaSeed development is pivotal in soybeanâ€™s lifecycle, directly determining yield and nutritional quality related to oil and protein contents. However, spatiotemporally resolved mechanisms underlying cell differentiation and nutrient accumulation during seed growth remain elusive, especially in wild soybean (Glycine soja Sieb. et Zucc.), which harbors rich genetic diversity for quality traits. Here, spatial transcriptomics and metabolomics were combined to dissect their dynamics in G. soja seeds at the mid-maturity stage. Differential expression analysis characterized the distinct accumulation patterns between adaxial and abaxial embryo parenchyma cells, revealing abaxial cells are enriched in protein metabolism pathways while adaxial cells focus on lipid metabolism pathways, which is consistent with previous studies reporting spatial nutrient accumulation in G. soja seeds. Meanwhile, pseudotemporal trajectory analyses briefly supported a sequential transcriptional regulation pattern for these differences. Cell-cell communication analysis further uncovered potential signaling interactions mediating cell-type-specific differences across seed cells. Key genetic regulators and differential metabolites were identified through spatial transcriptomics and metabolomics co-expression analysis, with GsMAPK23-4 screened as a core candidate linked to cotyledon nutrient metabolism. Functional validation confirmed GsMAPK23-4 modulates seed quality: knockout mutants had significantly higher amino acids and proteins. These findings elucidate the cellular characteristics and differentiation processes in G. soja seeds at the mid-maturity stage, providing a molecular basis for understanding this phase and generating targets to improve soybean yield and quality.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281215" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE294561 YTHDF3 ä¿ƒè¿› m6A å¯Œé›†çš„æœ‰ä¸åˆ†è£‚ç›¸å…³åŸºå› çš„ç¿»è¯‘ï¼Œä»è€Œå‡å¼±é£Ÿç®¡ç™Œå¯¹æ–°è¾…åŠ©åŒ–ç–—çš„ååº” [RIP-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€enrichmentã€resistanceã€depmap<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xiang Y Wang ; Ting wang ; Si M Zhao ; Zi G DongSeries Type : OtherOrganism : Homo sapiensNeoadjuvant chemotherapy (NACT) is a pivotal treatment strategy for esophageal cancer, significantly improving patient prognosis and 5-year survival rates. However, a substantial proportion of patients exhibit resistance to NACT and consequently fail to benefit from it. As NACT responsiveness is influenced by multiple distinct molecular pathways, it is essential to systematically investigate the mechanisms underlying poor therapeutic responses. In this study, we found that YTHDF3 directly enhances the m6A-dependent translation of key mitotic regulators, CDCA8 and INCENP, thereby reducing cellular sensitivity to NACT.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294561" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE281070 é‡ç”Ÿå¤§è±†ç§å­å‘è‚²çš„æ—¶ç©ºè½¬å½•ç»„å’Œä»£è°¢ç»„æ™¯è§‚æ­ç¤ºè¥å…»ç§¯ç´¯çš„è°ƒæ§æœºåˆ¶ [ç©ºé—´è½¬å½•ç»„å­¦]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€spatial transcriptomicsã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€proteomicsã€metabolomeã€metabolomicsã€Seuratã€Scanpyã€epigeneticã€enrichmentã€depmap<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : OtherOrganism : Glycine sojaSeed development is pivotal in soybeanâ€™s lifecycle, directly determining yield and nutritional quality related to oil and protein contents. However, spatiotemporally resolved mechanisms underlying cell differentiation and nutrient accumulation during seed growth remain elusive, especially in wild soybean (Glycine soja Sieb. et Zucc.), which harbors rich genetic diversity for quality traits. Here, spatial transcriptomics and metabolomics were combined to dissect their dynamics in G. soja seeds at the mid-maturity stage. Differential expression analysis characterized the distinct accumulation patterns between adaxial and abaxial embryo parenchyma cells, revealing abaxial cells are enriched in protein metabolism pathways while adaxial cells focus on lipid metabolism pathways, which is consistent with previous studies reporting spatial nutrient accumulation in G. soja seeds. Meanwhile, pseudotemporal trajectory analyses briefly supported a sequential transcriptional regulation pattern for these differences. Cell-cell communication analysis further uncovered potential signaling interactions mediating cell-type-specific differences across seed cells. Key genetic regulators and differential metabolites were identified through spatial transcriptomics and metabolomics co-expression analysis, with GsMAPK23-4 screened as a core candidate linked to cotyledon nutrient metabolism. Functional validation confirmed GsMAPK23-4 modulates seed quality: knockout mutants had significantly higher amino acids and proteins. These findings elucidate the cellular characteristics and differentiation processes in G. soja seeds at the mid-maturity stage, providing a molecular basis for understanding this phase and generating targets to improve soybean yield and quality.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281070" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE305309 äººèƒç›˜æ¥æºé—´å……è´¨å¹²ç»†èƒå‡å¼±è€å¹´å°é¼ æµ·é©¬è¡°è€ç›¸å…³è½¬å½•ç»„è°±</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€Hi-Cã€scRNAã€scDNAã€scATACã€spatialã€spatial transcriptomicsã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€proteomicsã€Seuratã€epigenomeã€methylationã€histoneã€enrichmentã€clusteringã€resistanceã€depmap<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusBackground Intravenous human placentaâ€“derived mesenchymal stem cells (hpMSCs) can improve tissue function through paracrine effects, but their impact on normal brain aging is not well defined. Methods Aged female mice (18â€“19 months) received three intravenous infusions of hpMSCs or PBS at six-week intervals. Hippocampal tissue was collected after the behavioral tests for RNA sequencing. Results RNA sequencing showed hpMSCs' effectiveness in modulating aging-related neural pathways, particularly by downregulating age-specific genes in the hippocampus, indicative of neural reactivation. Conclusions Systemic hpMSC administration modulates neural pathways in aged mice.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305309" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE285920 Piezo1 çš„æ¿€æ´»è¯±å¯¼ LSK ç»†èƒå¼‚è´¨æ€§ï¼Œå¯¼è‡´ HSC å¢æ®–å’Œé«“ç³»é€ è¡€ [scRNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€resistance<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xinjiang Lu ; Tongyao Shang ; Li Zhao ; Shibo YingSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusBone marrow haematopoietic stem cells (HSCs) are mobilised into blood under various stresses. Although they are exposed to shear stress during circulation, the role of mechanical stimulation in regulating HSCs remains unknown. Piezo1, a mechanosensory ion channel, was implicated in regulation of haematopoietic cells. We analysed the transcriptional heterogeneity of LSK cells from mice treated with the Piezo1 agonist Yoda1 for 2 weeks. Our study demonstrated that activation of Piezo1 promoted HSC proliferation and differentiation toward the myeloid lineage, as evidenced by an increase in HSC numbers and the upregulation of myeloid transcription factors.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285920" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>GSE289098 ç ”ç©¶å‘ç°ï¼Œç‚ç—‡ç›¸å…³çš„å¾®èƒ¶è´¨ç»†èƒå¢æ®–ä¼šç ´åæµ·é©¬èƒ¶è´¨ç»†èƒç½‘ç»œé€šè®¯ï¼Œä»è€Œå¯¼è‡´æœ¯åç¥ç»è®¤çŸ¥åŠŸèƒ½éšœç¢ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€transcriptomeã€proteomeã€R packageã€Seuratã€epigeneticã€epigenomeã€histoneã€clusteringã€resistanceã€depmap<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yuxiang Zheng ; Wenjie Xu ; Zizheng Suo ; Yinyin Qu ; Lina Lin ; Enze Zhang ; Dengyang Han ; Meikui Wu ; Hongyi Li ; Hui Zheng ; Ting Xiao ; Cheng NiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusPostoperative neurocognitive impairment (PNCI) significantly affects the recovery and long-term outcomes of elderly patients, with central nervous system (CNS) inflammation serving as the key pathogenic driver of its development. As the resident immune cells of the CNS, microglia play a crucial role in regulating perioperative inflammation and maintaining homeostasis. However, the contribution, phenotypic heterogeneity, and communication network of perioperative microglia in the development of PNCI remain insufficiently characterized. In this study, 18-month-old mice underwent surgery and developed PNCI. Single-cell RNA sequencing was performed, which identified eight microglial subpopulations and six astrocytic subpopulations in hippocampus. Postoperatively, the percentage of microglial subpopulations underwent dramatic changes, with inflammation associated microglia (IAM) increasing more than 14-fold and transition state microglia (TSM) increasing more than 33-fold. These alterations were accompanied by a marked enhancement of intercellular communications among glial cells, particularly driven by the activation of TNF signaling pathway in IAM. This pathway, along with its associated regulatory network, critically modulated the function of astrocytes and endothelial cells, thereby playing a pivotal role in CNS inflammation and the subsequent development of PNCI. Notably, administration of TNF inhibitor etanercept attenuated IAM activation and glial network communication in the hippocampus, which was associated with improved cognitive performance in PNCI mice.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289098" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>å¯¹æ³¨å°„Ad-creå’Œæ¥å—ä»–è«æ˜”èŠ¬æ²»ç–—åKrasLSL-G12D/+Lkb1fl/fl (KL)å’ŒKrasLSL-G12D/+Lkb1fl/flGpx4m/m (KLG4)å°é¼ è‚¿ç˜¤è‚ºä¸­çš„è‚¿ç˜¤ç»†èƒã€TRMã€MDMã€å•æ ¸ç»†èƒå’ŒCD8+ Tç»†èƒè¿›è¡ŒGSE281154 mRNAè½¬å½•ç»„æµ‹åº</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€leukemiaã€sequencingã€RNAseqã€single.cellã€scRNAã€scDNAã€scATACã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€R packageã€Seuratã€epigeneticã€epigenomeã€resistance<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Peng Wang ; Shengdan Zhang ; Xin Chen ; Dandan Lin ; Bo ZhongSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe transcriptional profiling of tumor cells, TRMs, MDMs, Monocytes and CD8+ T cells from tumor lungs of KL and KLG4 mice<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281154" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> â­ <strong>GSE246906 é€‰æ‹©æ€§é¶å‘Bæ·‹å·´ç»†èƒä¸­çš„MMP-12æ²»ç–—ä¸¥é‡è¿‡æ•æ€§æ°”é“ç–¾ç—…</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€lymphomaã€Hi-Cã€scRNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€pathway<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xijie Zhang ; Xinyu Jia ; Min Jia ; Manni Zhu ; Zhengxia Wang ; Zhongqi Chen ; Ningfei Ji ; Mao Huang ; Mingshun ZhangSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusInducible Bronchus-Associated Lymphoid Tissue (iBALTs), the tertiary immune organs in the lungs, have been implicated in various pulmonary diseases. The formation and roles of iBALTs related to severe asthma, however, remain unclear. iBALTs was located near the area of bronchi and vessels in the severe asthma murine model induced by house dust mite (HDM) extract and lipopolysaccharides (LPS). Repeated sensitizations promoted the formation of iBALTs, which disappeared 2 weeks post last HDM challenge. The neutralizing antibody of CXCL13 prevented the formation of iBALTs but failed to relieve the airway inflammation. B lymphocytes dominated in iBALTs. Compared with the control group, severe asthma group had increased IgE secreting cells. Bulk RNA-seq reveled the elevated MMP-12 in pulmonary B cells. MMP408, a specific MMP-12 inhibitor, reduced iBALTs formation. Moreover, AAV-6 targeting down MMP-12 in B lymphocytes blocked iBALTs and ameliorated the inflammation. These results indicated that MMP-12 from B lymphocytes motivated the aggregation of B lymphocytes, promoted the formation of iBALTs and further sharpened the inflammation of severe asthma.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE246906" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> â­ <strong>GSE140320 ç»†èƒå¤–å›Šæ³¡çš„åŠŸèƒ½å’Œè½¬å½•ç»„åˆ†æå‘ç°é’™ä¿æŠ¤è›‹ç™½æ˜¯å¤–å‘¨åŠ¨è„‰ç–¾ç—… (PAD) çš„ä¸€ç§æ–°çš„é¢„åæ ‡å¿—ç‰©</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€carcinomaã€scRNAã€scDNAã€scATACã€10xã€spatialã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€Seuratã€Scanpyã€clusteringã€resistanceã€depmap<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Goren Saenz-Pipaon ; Patxi San MartÃ­n ; NÃºria Planell ; Alberto Maillo ; Susana Ravassa ; Amaia Vilas-Zornoza ; Esther MartÃ­nez-Aguilar ; JosÃ© A Rodriguez ; Daniel Alameda ; David Lara-Astiaso ; Felipe Prosper ; JosÃ© A Paramo ; Josune Orbe ; David Gomez-Cabrero ; Carmen RoncalSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensRationale: Peripheral arterial disease (PAD) is associated with a high risk of cardiovascular events and death and is postulated to be a critical socioeconomic cost in the future. Extracellular vesicles (EVs) have emerged as potential candidates for new biomarker discovery related to their protein and nucleic acid cargo.Objective: To study prothrombotic activity, cellular origin and transcriptomic profile of circulating EVs and to assess them as prognostic and therapeutic targets in PAD.Methods and Results: This prospective study included control and PAD patients. Coagulation time (Procoag-PPL kit), EVs cellular origin and phosphatidylserine exposure were determined by flow cytometry in platelet-free plasma (n=45 PAD). Transcriptomic profiles of medium/large EVs were generated using the MARS-Seq RNA-Seq protocol (n=12/group). The serum concentration of the differentially expressed gene calprotectin was validated by ELISA in control (n=100) and PAD patients (n=317). Calprotectin was also determined in EVs and tissues of human atherosclerotic plaques (n=3). Circulating EVs of PAD patients were mainly of platelet origin, predominantly AnnexinV positive and were associated with the procoagulant activity of platelet-free plasma. Transcriptomic analysis of EVs identified 15 differentially expressed genes. Among them, serum calprotectin was elevated in PAD patients (pConclusions: We found that PAD patients release EVs, mainly of platelet origin, highly positive for AnnexinV and rich in transcripts related to platelet biology and immune responses. Amputation risk prediction improved with calprotectin and was significantly higher when combined with hs-CRP. Our results suggest that EVs can be a promising component of liquid biopsy with prognostic implications in PAD.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE140320" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>11.</strong> â­ <strong>GSE276733 é€šè¿‡ FIRESCAPE è¿›è¡Œçš„ç”Ÿç‰©åˆ†å­è¿½è¸ªæ­ç¤ºäº†ç»†èƒå¤–ç»„è›‹ç™½ H3 çš„æ¸…é™¤ã€æŸä¼¤è¯±å¯¼å’Œç»†èƒæ‘„å–çš„ä¸åŒæ¨¡å¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€carcinomaã€leukemiaã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€bioinformaticsã€Bioconductorã€Seuratã€histoneã€resistance<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Adam P CribbsSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Rattus norvegicusThe study of chromatin has mostly been restricted to defining its function in the nucleus, where histone proteins fulfil vital roles in packaging genomic DNA and regulating transcription. However, chromatin components are often released into the extracellular space, either intentionally via cellular secretion or during disease or damage-induced cell death. These extracellular chromatin components, depending on the context, can consist of free histones, free DNA, intact nucleosomes (histone octamers wrapped by DNA), or heterogeneous, higher order structures such as neutrophil extracellular traps (NETs). They have been associated with diverse pathologies such as inflammation, cancer, and sepsis, and distinct toxic effects, most notably the damaging effects of free histones over intact nucleosomes. Extracellular chromatin components are emerging, suggested biomarkers for various associated diseases, yet there is a widely acknowledged lack of methods that distinguish between them and their unique functions in circulation. Here, we explore the fate and effects of extracellular free histone H3 by utilizing FIRESCAPE ([18F]-Fluorine Isotopic Radiolabeling Enabling Scanning of Clearance After Proteolytic Events), a novel radiolabeling concept that leverages the unique, high-sensitivity properties of the radioisotope 18F and residue-specific protein editing chemistry. By installing true 18F-containing protein sidechain mimics site-specifically into histone H3, FIRESCAPE enabled in vivo scanning of the half-lives, proteolytic susceptibility, and clearance of single residues in a protein of interest, at microdoses far below toxic levels (low nanomole). This now precisely reveals the remarkably distinct distribution, half-lives, damage-inducing abilities, and accumulation of free extracellular histones in cellulo and in vivo, comparing them to other chromatin states such as intact nucleosomes where appropriate. Free extracellular histones are rapidly cleared from circulation, first mediated by proteolysis of the histone tail. However, direct injection of free histones versus nucleosomes into tissue (brain) that is unprotected by such proteolysis provokes a starkly different response: free histones exhibited limited diffusion and swiftly promoted damage both in cell culture and in vivo, in contrast to the largely passive and benign nature...<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE276733" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>12.</strong> â­ <strong>GSE305310 äººèƒç›˜é—´å……è´¨å¹²ç»†èƒç»†èƒå¤–å›Šæ³¡çš„ miRNA-Seq</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€RNA-seqã€RNAseqã€scRNAã€scDNAã€scATACã€10xã€spatialã€genomeã€genomicsã€Seuratã€Scanpyã€enrichmentã€resistance<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Non-coding RNA profiling by high throughput sequencingOrganism : Homo sapiensExtracellular vesicles (EVs) released by human placentaâ€“derived mesenchymal stem cells (hpMSCs) are thought to mediate paracrine effects. To characterize their small-RNA cargo, we isolated hpMSC-derived EVs (hpEVs) from conditioned media using size-exclusion chromatography and performed miRNA sequencing.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305310" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>13.</strong> â­ <strong>GSE285919 Piezo1 ç¼ºé™·è¯±å¯¼ HSC è½¬å½•ç»„å˜åŒ– [RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€RNA-seqã€RNAseqã€DNA-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€Seurat<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xinjiang Lu ; Tongyao Shang ; Li Zhao ; Shibo YingSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusWe found that haematopoietic cell-specific Piezo1 knockout (KO) inhibits HSC proliferation and myeloid differentiation. To identify the underlying mechanism, we analysed the gene expression profiles of long-term haematopoietic stem cells (LT-HSCs) from Piezo1 KO mice and compared them with those from control mice. Our study demonstrated that the tight junction pathway was one of the enriched terms among downregulated genes in Piezo1 KO HSCs, with a decrease in JAM3 expression.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285919" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>14.</strong> â­ <strong>GSE275329 MeCP2 ä¸è¶…å»¶ä¼¸å¤åˆç‰©ç›¸äº’ä½œç”¨ä»¥è°ƒæ§è½¬å½•ï¼ˆChIP-Seqï¼‰</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€RNA-seqã€RNAseqã€ChIP-seqã€ATAC-seqã€scRNAã€scATACã€spatialã€genomeã€genomicsã€Seuratã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jun Y Sonn ; Marta Iwanaszko ; Huda Y Zoghbi ; Ali ShilatifardSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusLoss-of-function mutations in methyl-CpG binding protein 2 (MECP2) cause the neurodevelopmental disorder, Rett syndrome (RTT). The molecular mechanisms underlying MeCP2 function remain poorly understood. Here, using a MECP2 gain-of-function Drosophila model, we screened for genetic modifiers of MECP2-induced toxicity. Our approach identified several subunits of the Drosophila super elongation complex (SEC), a P-TEFb containing elongation factor that releases promoter-proximally paused RNA polymerase II (RNA pol II), as genetic interactors of MECP2. MeCP2 directly interacts with AFF4, the scaffold of the SEC, and facilitates its binding on a subset of genes that regulate neuronal development and synaptic function in the mouse cortex. Furthermore, genes with reduced AFF4 binding showed reduced RNA pol II binding in their genebody and decreased RNA expression in Mecp2 null mice. Taken together, we propose that MeCP2 interacts with the SEC to facilitate the release of RNA pol II and thereby support gene expression.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275329" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>15.</strong> â­ <strong>GSE275332 MeCP2 ä¸è¶…å»¶ä¼¸å¤åˆç‰©ç›¸äº’ä½œç”¨ä»¥è°ƒæ§è½¬å½•ï¼ˆRNA-Seqï¼‰</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€RNA-seqã€RNAseqã€ChIP-seqã€ATAC-seqã€scRNAã€scATACã€spatialã€genomeã€Seuratã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jun Y Sonn ; Marta Iwanaszko ; Ali Shilatifard ; Huda Y ZoghbiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusLoss-of-function mutations in methyl-CpG binding protein 2 (MECP2) cause the neurodevelopmental disorder, Rett syndrome (RTT). The molecular mechanisms underlying MeCP2 function remain poorly understood. Here, using a MECP2 gain-of-function Drosophila model, we screened for genetic modifiers of MECP2-induced toxicity. Our approach identified several subunits of the Drosophila super elongation complex (SEC), a P-TEFb containing elongation factor that releases promoter-proximally paused RNA polymerase II (RNA pol II), as genetic interactors of MECP2. MeCP2 directly interacts with AFF4, the scaffold of the SEC, and facilitates its binding on a subset of genes that regulate neuronal development and synaptic function in the mouse cortex. Furthermore, genes with reduced AFF4 binding showed reduced RNA pol II binding in their genebody and decreased RNA expression in Mecp2 null mice. Taken together, we propose that MeCP2 interacts with the SEC to facilitate the release of RNA pol II and thereby support gene expression.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275332" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>16.</strong> â­ <strong>GSE302903 12 ä¾‹ç»“ç›´è‚ ç™Œ (CRC) æ‚£è€…è‚¿ç˜¤ç»„ç»‡çš„å•ç»†èƒ RNA æµ‹åºã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€sequencingã€RNAseqã€single.cellã€single-cellã€scRNAã€scATACã€genomeã€genomicsã€Seurat<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zhuoqing Xu ; Haoran Feng ; Zichao Guo ; Wenqing Jia ; Tao Zhang ; Kun Liu ; Ren Zhao ; Xi ChengSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensSurgical specimens of tumor tissues from 12 colorectal cancer (CRC) patients were included. All cases were consecutively enrolled and cytologically or histologically confirmed as rectal adenocarcinoma by at least two pathologists, with no history of prior neoadjuvant anti-tumor therapy.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302903" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>17.</strong> â­ <strong>GSE302902 è¯ç‰©æµ‹åºç ”ç©¶ï¼šç»“ç›´è‚ ç™Œæ‚£è€…ä½“å†…é«˜å¯†åº¦ä¸­æ€§ç²’ç»†èƒ (HDN)ã€æˆç†Ÿä½å¯†åº¦ä¸­æ€§ç²’ç»†èƒ (M-LDN) å’Œæœªæˆç†Ÿä½å¯†åº¦ä¸­æ€§ç²’ç»†èƒ (IM-LDN)</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€Hi-Cã€spatialã€genomeã€proteomeã€Seuratã€methylationã€histoneã€resistanceã€depmap<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zhuoqing Xu ; Haoran Feng ; Wenqing Feng ; Yuchen Zhang ; Jianting Huo ; Zifeng Xu ; Fangqian Chen ; Han Gao ; Zeping Lv ; Wangyi Liu ; Abudumaimaitijiang Tuersun ; Suyue Yu ; Wenchang Li ; Yaping Zong ; Xiaohui Shen ; Xi Cheng ; Jingkun Zhao ; Aiguo LuSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensHigh-density neutrophils (HDNs), mature low-density neutrophils (M-LDN), and immature low-density neutrophils (IM-LDN) were isolated from peripheral blood of nine treatment-naÃ¯ve colorectal cancer (CRC) patients with histologically confirmed diagnoses, followed by gene expression profiling of these neutrophil subsets using Digital RNA with pertUrbation of Genes (DRUG) sequencing.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302902" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>18.</strong> â­ <strong>GSE302900 è¯ç‰©æµ‹åºç ”ç©¶ï¼šç»“ç›´è‚ ç™Œæ‚£è€…é«˜å¯†åº¦ä¸­æ€§ç²’ç»†èƒï¼ˆHDNï¼‰çš„GM-CSFåˆºæ¿€ä¸å¦</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€sequencingã€Hi-Cã€scRNAã€genomeã€genomicsã€Seuratã€histoneã€resistanceã€depmap<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zhuoqing Xu ; Haoran Feng ; Wenqing Feng ; Yuchen Zhang ; Jianting Huo ; Zifeng Xu ; Fangqian Chen ; Han Gao ; Zeping Lv ; Wangyi Liu ; Abudumaimaitijiang Tuersun ; Suyue Yu ; Wenchang Li ; Yaping Zong ; Xiaohui Shen ; Xi Cheng ; Jingkun Zhao ; Aiguo LuSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensHigh-density neutrophils (HDNs) were isolated from peripheral blood of three treatment-naÃ¯ve colorectal cancer (CRC) patients with histologically confirmed colorectal adenocarcinoma, then divided into PBS-treated controls (Ctrl) and GM-CSF-treated groups (GMCSF, 10 ng/mL, 16 hours) prior to Digital RNA with pertUrbation of Genes (DRUG) Sequencing analysis of stimulation-dependent gene expression profiles.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302900" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>19.</strong> â­ <strong>GSE281010 PRC1ä»‹å¯¼POGZåœ¨ç¥ç»å‘è‚²åŸºå› è°ƒæ§ä¸­çš„è½¬å½•æŠ‘åˆ¶åŠŸèƒ½</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€carcinomaã€scRNAã€scDNAã€scATACã€spatialã€genomeã€transcriptomeã€proteomeã€Seuratã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jessenia Chavez ; Zhonghua Gao ; James StaffordSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusPolycomb Repressive Complex 1 (PRC1) is a family of fundamental epigenetic regulators crucial for gene silencing and mammalian development. Elucidating the PRC1 composition and function in context- and stage-specific functions during differentiation and development is crucial in understanding the impact of PRC1-mediated transcriptional activity in these processes. This study focuses on the identification and characterization of POGZ, a high-risk Autism risk gene, as a novel component of the PRC1 complex in neural cells. Our biochemical analyses demonstrate that POGZ specifically interacts with the PRC1.6 complex to form the novel PRC1-POGZ complex. Functional assays indicate that POGZ elicits strong transcriptional repressor activity that is dependent on RING1B expression. ChIP-Seq studies determined that PRC1-POGZ localizes at neurodevelopmental genes in the embryonic mouse cortex. Although POGZ knockout (KO) does not compromise mESC pluripotency, POGZ ablation in neural precursor cells resulted in severe dysregulation of transcriptomic gene expression, marked by failed activation of key neural marker genes. Mechanistically, PRC1-POGZ target genes involved in multiple aspects of neuronal differentiation were differentially expressed in POGZ KO NPCs, which may explain the observed failed differentiation. The insights gained herein provide critical insights toward understanding how PRC1-POGZ function influences neural cell fate determination.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281010" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>20.</strong> â­ <strong>GSE307146 å¶é…¸å’Œç”²åŸºä¸™äºŒé…¸å¯¹å¿ƒè¡€ç®¡ç–¾ç—…æ­»äº¡ç‡çš„ç‹¬ç«‹äº¤äº’ä½œç”¨</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€Seuratã€epigenetic<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xinyu Zhang ; Chunping Wang ; Jinfeng Wang ; Xin Liu ; Shengnan Zhao ; Tuanwei Wang ; Peng WangSeries Type : Expression profiling by high throughput sequencingOrganism : Rattus norvegicusObjective: To investigate the independent and interactive effects of circulating folate and methylmalonic acid (MMA) status on cardiovascular disease (CVD) mortality. Methods: This study included 22,487 individuals from the U.S. National Health and Nutrition Examination Survey (NHANES) between 1999 and 2014. Kaplan-Meier and weighted Cox proportional hazards models were used to assess the associations of folate and MMA with CVD mortality. Restricted cubic splines (RCS) evaluated nonlinear relationships. Additive interaction method explored interactive effects. Sensitivity analysis tested the robustness of the findings. In vitro, CCK-8 assays were performed to assess the combined effects of folate and MMA on H9c2 cardiomyocyte viability. Transcriptomic analysis identified differentially expressed genes (DEGs) and their enriched pathways. Results: During 12.1 years of median follow-up, 1,510 cardiovascular deaths (4.4%) were recorded. RCS analysis demonstrated a U-shaped association between folate levels and CVD mortality, and a linear association for MMA. When MMA â‰¤ 182 nmol/L, folate levels were not associated with CVD mortality. However, among individuals with MMA &gt; 182 nmol/L, both low and high folate levels were significantly associated with higher CVD mortality, with adjusted hazard ratios (aHRs) of 1.43 (95% CI: 1.19-1.71) and 2.36 (95% CI: 1.85-3.00), respectively (both P &lt; 0.001). An additive interaction between folate and MMA on CVD mortality (RERI: 0.82 [95% CI: 0.06-1.58], API: 0.35 [95% CI: 0.03-0.67]; SI: 1.57 [95% CI: 1.27-2.00]). Sensitivity analyses confirmed these findings. In vitro, MMA (8 mM) significantly enhanced folate-induced (1.6 mM) cytotoxicity, reducing cell viability to 49.26% (P &lt; 0.001). Transcriptomic analysis revealed 53 DEGs under combined treatment, enriched in inflammation-related pathways. Conclusions: Both population-based and experimental evidence suggest that elevated folate and MMA levels independently increase CVD mortality risk, with their interaction synergistically exacerbating cardiovascular outcomes.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307146" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>21.</strong> â­ <strong>GSE305755 RPA ç›´æ¥åˆºæ¿€ Mer3/HFM1 è§£æ—‹é…¶çš„æŒç»­æ´»æ€§ï¼Œä»¥ç¡®ä¿å‡æ•°åˆ†è£‚ä¸­æ­£å¸¸çš„äº¤å‰å½¢æˆ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€scRNAã€scATACã€spatialã€genomeã€proteomeã€Seuratã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Valerie BordeSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Saccharomyces cerevisiae ; Saccharomyces mikataeMeiotic crossover formation is critical for generating viable gametes and enhancing genetic diversity. The helicase Mer3 (HFM1 in humans) is a highly conserved factor essential for promoting crossovers and ensuring their proper distribution. Here, we identify replication protein A (RPA) as a direct interactor of budding yeast Mer3. We demonstrate that this interaction is conserved between human HFM1 and RPA. Cross-linking mass spectrometry and structural modelling with AlphaFold2 reveal a conserved and specific Mer3-RPA interface. Single-molecule magnetic tweezers assays demonstrate that direct RPA interaction is required for Mer3 helicase processivity under conditions of low DNA tension. Consistently, mer3 mutant deficient in RPA binding exhibit reduced crossover frequencies and accumulate unresolved recombination intermediates during budding yeast meiosis. Via genome-wide localisation experiments, we link this effect to a weakened recruitment to double-strand break sites of the mer3 mutant. Our findings provide mechanistic insights into coordination of meiotic recombination by the Mer3 helicase through interactions with the canonical DNA repair machinery, highlighting a conserved mechanism underlying crossover control during sexual reproduction.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305755" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>22.</strong> â­ <strong>GSE152864 ä½å‰‚é‡å’Œé«˜å‰‚é‡è…ºç—…æ¯’æ„ŸæŸ“åè‚è„ CD8 T ç»†èƒç¾¤ mRNA çš„ RNA æµ‹åº</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNAseqã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€Seuratã€histoneã€clustering<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Verena KÃ¶nig ; Miriam Bosch ; Nina Kallin ; Sainitin Donakonda ; Rupert Oellinger ; Thomas Engleitner ; Percy A KnolleSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusWe aimed at dissecting phenotype, functionality and regulation of antigen-specific hepatic CD8 T cells after low dose or during high dose infection of the liver.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE152864" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>23.</strong> â­ <strong>GSE307042 ä¿å®ˆçš„çƒ­æ¿€å› å­é€šè¿‡ä¸åŒçš„æœºåˆ¶æ§åˆ¶å¤§éº¦çš„çƒ­èƒè¿«è®°å¿† - æ‰©å±•é‡å¤</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€Hi-Cã€scRNAã€scDNAã€scATACã€genomeã€genomicsã€Seuratã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Loris Pratx ; Christian Kappel ; Isabel BÃ¤urleSeries Type : Expression profiling by high throughput sequencingOrganism : Hordeum vulgareClimate change requires optimizing stress responses in crops. Priming and memory of heat stress (HS) allow plants to improve their tolerance against high temperatures. Here, we investigate HS memory in cultivated barley (Hordeum vulgare) to assess whether the mechanisms underlying priming by and memory of HS are conserved between dicots and monocots. Mutation of the barley orthologs of two key transcriptional regulators of HS memory, HvHSFA2 and HvHSFA3, reduced HS memory. This correlated with altered transcriptional responses of heat-induced genes in the mutants after recurrent HS. Conversely, overexpression of HvHSFA2 increases HS tolerance with no penalty on productivity. While the biological role of HSFA2 and HSFA3 is conserved, their mechanistic functions appear to have diverged, as we did not find evidence that HvHSFA2 is involved in H3K4me-mediated priming. Instead, both factors are globally required to boost induction of HS-responsive genes after recurrent HS. In summary, while barley HS memory depends on the highly conserved HvHSFA2 and HvHSFA3, the underlying transcriptional wiring is different. Our findings provide a tangible route to improve HS tolerance in temperate cereals.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307042" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>24.</strong> â­ <strong>GSE306015 å¾ªç¯ç»†èƒå¤–å›Šæ³¡åœ¨æ…¢æ€§è‚¾è„ç—…æ‚£è€…å¿ƒåŠ›è¡°ç«­å‘ç—…æœºåˆ¶ä¸­çš„ä½œç”¨</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€scRNAã€scDNAã€scATACã€spatialã€Seuratã€Scanpyã€histoneã€resistance<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xisheng Li ; Nikhil Raisinghani ; Alex Gallinat ; Carlos Santos-Gallego ; Shihong Zhang ; Sabrina La Salvia ; Seonghun Yoon ; Hayrettin Yavuz ; Anh Phan ; Alan Shao ; Michael Harding ; David Sachs ; Carol Levy ; Navneet Dogra ; Nicole Dubois ; Rupangi Vasavada ; Uta Erdbruegger ; Susmita SahooSeries Type : Non-coding RNA profiling by high throughput sequencingOrganism : Homo sapiensBackground: Cardiovascular disease (CVD) causes more than 50% of deaths in patients with advanced chronic kidney disease (CKD). CVD degree correlates with CKD severity. Clinical studies suggest that kidney-derived factors contribute to the development of CVD in CKD, independently of co-morbidities like hypertension and hyperglycemia. However, to date, no kidney-specific humoral risk factor that triggers direct cardiotoxicity has yet been identified, primarily due to the paucity of studies in patients with reno-cardiac disease. Here, we investigate how, in CKD patients, circulating extracellular vesicles (EVs) facilitate pathological kidney-heart communication, thereby causing cardiotoxicity, impairing cardiac function and contributing to heart failure (HF) progression. Methods and results: EVs isolated from the plasma of patients with CKD (hCKD-EVs), but not healthy controls (hCtr-EVs), were cardiotoxic, significantly inducing apoptosis both in vitro and in vivo and impairing contractility of isolated adult rat primary CMs in vitro. Likewise, EVs isolated from both plasma and kidneys of adenine diet-induced CKD mice were also cardiotoxic. Pharmacologically depleting circulating EVs in CKD mice significantly recovered cardiac function and ameliorated HF, suggesting CKD-EVs play a causal role in HF pathogenesis. Small RNA sequencing and q-RT-PCR validation uncovered distinct miRNAs enriched in both human and mouse CKD-EVs, compared to Ctr-EVs. CKD-EV-miRNA mimics were cardiotoxic to human ventricular AC16 myocytes inducing apoptosis and to iPSC-derived cardiomyocytes, impairing contractility and downregulating contractile gene expression. Interestingly, levels of endogenous primary miRNAs corresponding to CKD-EV-miRNAs were significantly higher in CKD-kidney tissues, specifically in CD45-veCD31-ve renal cells, but not in CKD-livers, CKD-lungs or CKD-PBMCs from peripheral blood, a result that suggests that CKD-EV-miRNAs originate renally. Remarkably, CKD-EV-miRNA levels correlated with established markers of cardiac injury, uncovering the presence of sub-clinical hea...<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306015" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>25.</strong> â­ <strong>GSE305194 ç»†èƒæ­»äº¡æ³¢è°ƒèŠ‚äººç±»è§†ç½‘è†œç¥ç»èŠ‚ç»†èƒçš„æ•°é‡å’Œæˆç†Ÿåº¦</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€scRNAã€scDNAã€scATACã€genomeã€genomicsã€Seurat<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jingliang S Zhang ; Brian Guy ; Clayton P Santiago ; Caterina Tiozzo ; Meghana Sreenath ; Ya-Wen Chen ; Seth Blackshaw ; Robert J Johnston JrSeries Type : Genome binding/occupancy profiling by high throughput sequencing ; Expression profiling by high throughput sequencingOrganism : Homo sapiensRetinal ganglion cells (RGCs) are the projection neurons that transmit visual information from the retina to the brain via the optic nerve. A substantial proportion of RGCs are eliminated by programmed cell death during development to regulate their final number, yet how cell death impacts RGC development in human retinas remains poorly understood. Here, we characterized the timing and cell-type-specificity of cell death in human fetal retinas and retinal organoids. We identified two waves of apoptosis: an early wave targeting retinal neuronal precursors and a late wave affecting RGCs and other neurons. In addition to these two waves of apoptosis, organoids displayed a distinct wave of necrosis in the innermost core region that eliminates nearly all RGCs during long-term culture. To investigate the functions of the apoptotic waves during retinal development, we differentiated BAX/BAK double mutant organoids that are deficient for apoptosis. In these mutant organoids, RGC survival was improved, RGC neurogenesis and maturation were delayed, and RGCs were lost through a compensatory increase in necrosis. Our data suggest that the waves of developmental apoptosis promote human RGC neurogenesis and maturation. Together, our results highlight the roles of cell death in human RGC development and the challenges in retinal organoid design. Overcoming these obstacles would improve the utility of retinal organoids for modeling optic neuropathies like glaucoma<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305194" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 7 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ”¬ æœŸåˆŠæ–‡ç«  (14æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨14æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>ç™Œç—‡ä¸­ç»†èƒæ­»äº¡å…ç–«ä¸²æ‰°çš„æ²»ç–—é¶å‘ä»¥é‡æ–°è¿æ¥è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç™Œç—‡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: å…ç–«ç³»ç»Ÿé€šè¿‡åè°ƒæŠ‘åˆ¶æ¶æ€§è‚¿ç˜¤çš„å‘ç”Ÿã€è¿›å±•å’Œè½¬ç§»çš„æŠ—è‚¿ç˜¤ååº”ï¼Œåœ¨æŠ—ç™Œé˜²å¾¡ä¸­å‘æŒ¥æ ¸å¿ƒä½œç”¨ã€‚æ–°å‡ºç°çš„è¯æ®å¼ºè°ƒäº†è°ƒèŠ‚ç»†èƒæ­»äº¡ ï¼ˆRCDï¼‰ é€”å¾„ä¸å…ç–«æ¿€æ´»ï¼ˆç‰¹åˆ«æ˜¯å…ç–«åŸæ€§ç»†èƒæ­»äº¡ ï¼ˆICDï¼‰ï¼‰ä¹‹é—´è‡³å…³é‡è¦çš„ç›¸äº’ä½œç”¨ã€‚ICD æ˜¯æŒ‡è‚¿ç˜¤ç»†èƒæ­»äº¡å¹¶é‡Šæ”¾æŸä¼¤ç›¸å…³åˆ†å­æ¨¡å¼ï¼ˆDAMPï¼‰å’Œå…¶ä»–ä¿¡å·åˆ†å­ï¼Œä»è€Œé‡å¡‘è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒï¼ˆTIMEï¼‰çš„ä¸€ç§ç‰¹å®šå½¢å¼çš„è°ƒèŠ‚æ€§ç»†èƒæ­»äº¡ã€‚è™½ç„¶è§„èŒƒçš„ RCD é€”å¾„å·²ç»å¾ˆæˆç†Ÿï¼Œä½† ICD çš„è¯±å¯¼å› å­ã€TIME åŠ¨åŠ›å­¦çš„æ—¶ç©ºè°ƒèŠ‚ä»¥åŠå…ç–«ç»†èƒçš„åŠŸèƒ½çŠ¶æ€ä»ä¸å®Œå…¨æ¸…æ¥šã€‚æˆ‘ä»¬å½»åº•è¯„ä¼°äº†åˆ©ç”¨ RCD é©±åŠ¨çš„å…ç–«è°ƒèŠ‚ä½œç”¨æœºåˆ¶çš„å½“ä»£æ²»ç–—æ–¹æ³•ï¼ŒåŒ…æ‹¬å¢å¼º ICD å’Œå¢å¼ºæŠ—è‚¿ç˜¤å…ç–«ååº”çš„ç­–ç•¥ã€‚æœ¬ç»¼è¿°çš„æ–°é¢–ä¹‹å¤„åœ¨äºå…¶åŒé‡è§†è§’ï¼šæè¿°è‚¿ç˜¤å†…åœ¨æ­»äº¡ç¨‹åºå¦‚ä½•é‡æ–°ç¼–ç¨‹è‚¿ç˜¤ TIMEï¼Œä»¥åŠå…ç–«ç»†èƒæ­»äº¡å¦‚ä½•ç›´æ¥å†³å®šå…¶å‘å…ç–«åˆºæ¿€çŠ¶æ€ä¸å…ç–«æŠ‘åˆ¶çŠ¶æ€çš„æåŒ–ï¼Œæœ€ç»ˆå½±å“æ²»ç–—ç»“æœã€‚æˆ‘ä»¬æ·±å…¥åˆ†æäº†ä¸åŒå½¢å¼çš„ RCD å¦‚ä½•å¡‘é€ æŠ—åŸå‘ˆé€’ã€å¼•å¯¼<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1984490885049131008/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>å…³äºé¥®é…’å¯¹ç¾å›½æˆå¹´äººæ‚£ç™Œç—‡é£é™©å½±å“çš„ä¿¡å¿µã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext:<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1984287905758748672/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>æ¬§æ´²æˆ˜èƒœç™Œç—‡è®¡åˆ’å› â€œç«‹æ³•ä¸ä½œä¸ºâ€è€Œè¢«æ¨è¿Ÿ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: æš‚æ— æ‘˜è¦<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1984449569024024576/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>äººå·¥æ™ºèƒ½åœ¨ç™Œç—‡ä¸­çš„åº”ç”¨ã€æŒ‘æˆ˜å’Œæœªæ¥å±•æœ›</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: äººå·¥æ™ºèƒ½ ï¼ˆAIï¼‰ æ­£åœ¨è¿…é€Ÿå½»åº•æ”¹å˜è‚¿ç˜¤å­¦ç ”ç©¶çš„æ ¼å±€å’Œä¸ªæ€§åŒ–ä¸´åºŠå¹²é¢„çš„è¿›æ­¥ã€‚ä¸‰ä¸ªç›¸äº’å…³è”çš„é¢†åŸŸçš„è¿›å±•ï¼ŒåŒ…æ‹¬è®­ç»ƒäººå·¥æ™ºèƒ½æ¨¡å‹çš„æ–¹æ³•å’Œç®—æ³•çš„å¼€å‘ã€ä¸“ä¸šè®¡ç®—ç¡¬ä»¶çš„å‘å±•ä»¥åŠæˆåƒã€åŸºå› ç»„å­¦å’Œä¸´åºŠä¿¡æ¯ç­‰å¤§é‡ç™Œç—‡æ•°æ®çš„è®¿é—®å¢åŠ ï¼Œå·²ç»èåˆåœ¨ä¸€èµ·ï¼Œå¯¼è‡´äººå·¥æ™ºèƒ½åœ¨ç™Œç—‡ç ”ç©¶ä¸­çš„æ–°åº”ç”¨å‰æ™¯å¹¿é˜”ã€‚äººå·¥æ™ºèƒ½åº”ç”¨æ ¹æ®ç‰¹å®šçš„ç™Œç—‡ç±»å‹å’Œä¸´åºŠé¢†åŸŸè¿›è¡Œç³»ç»Ÿç»„ç»‡ï¼ŒåŒ…æ‹¬ç”Ÿç‰©å­¦æœºåˆ¶çš„é˜æ˜å’Œé¢„æµ‹ã€ä¸´åºŠæ•°æ®ä¸­æ¨¡å¼çš„è¯†åˆ«å’Œåˆ©ç”¨ä»¥æ”¹å–„æ‚£è€…é¢„åï¼Œä»¥åŠæ­ç¤ºæµè¡Œç—…å­¦ã€è¡Œä¸ºå’Œç°å®ä¸–ç•Œæ•°æ®é›†ä¸­å›ºæœ‰çš„å¤æ‚æ€§ã€‚å½“ä»¥é“å¾·å’Œç§‘å­¦ä¸¥è°¨çš„æ–¹å¼åº”ç”¨æ—¶ï¼Œè¿™äº›äººå·¥æ™ºèƒ½é©±åŠ¨çš„æ–¹æ³•æœ‰æœ›åŠ é€Ÿç™Œç—‡ç ”ç©¶çš„è¿›å±•ï¼Œå¹¶æœ€ç»ˆä¿ƒè¿›æ”¹å–„æ‰€æœ‰äººç¾¤çš„å¥åº·ç»“æœã€‚æˆ‘ä»¬å›é¡¾äº†å±•ç¤ºäººå·¥æ™ºèƒ½åœ¨è‚¿ç˜¤å­¦ä¸­æ•´åˆçš„ä¾‹å­ï¼Œé‡ç‚¹ä»‹ç»äº†æ·±åº¦å­¦ä¹ å·§å¦™åœ°è§£å†³äº†æ›¾ç»è¢«è®¤ä¸ºæ— æ³•å…‹æœçš„æŒ‘æˆ˜çš„æ¡ˆä¾‹ï¼ŒåŒæ—¶è¿˜è®¨è®ºäº†ä¸ºä¿ƒè¿›è¿™äº›æŠ€æœ¯çš„æ›´å¹¿æ³›é‡‡ç”¨è€Œå¿…é¡»å…‹æœçš„éšœç¢ã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1983991675744854016/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>I å‹å¹²æ‰°ç´ ä¿¡å·ä¼ å¯¼å¯¹ç™Œç—‡çš„èƒŒæ™¯ä¾èµ–æ€§å½±å“</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: é•¿æœŸä»¥æ¥ï¼ŒI å‹å¹²æ‰°ç´  ï¼ˆIFNï¼‰ ä¸€ç›´è¢«è®¤ä¸ºæ˜¯åˆ†å­æœºåˆ¶çš„å…³é”®ç»„æˆéƒ¨åˆ†ï¼Œè¯¥åˆ†å­æœºåˆ¶é¦–å…ˆå¯¹å¤šç»†èƒçœŸæ ¸ç”Ÿç‰©ä¸­çš„ç—…æ¯’æ„ŸæŸ“åšå‡ºååº”ã€‚æœ€è¿‘ï¼ŒI å‹å¹²æ‰°ç´ ä¿¡å·ä¼ å¯¼ä¹Ÿå·²æˆä¸ºè‡ªç„¶å‘å±•çš„è‚¿ç˜¤ä»¥åŠå¯¹ï¼ˆå…ç–«ï¼‰æ²»ç–—æœ‰ååº”çš„è‚¿ç˜¤çš„å¾®ç¯å¢ƒä¸­çš„å¸¸è§è¿‡ç¨‹ã€‚åœ¨è¿™ç§æƒ…å†µä¸‹ï¼Œç¨³å¥ã€æ€¥æ€§ä½†æœ€ç»ˆè§£å†³çš„ I å‹å¹²æ‰°ç´ ååº”ä¼¼ä¹é€šè¿‡å¤šç§æœºåˆ¶æ”¯æŒè‡ªç„¶å’Œæ²»ç–—é©±åŠ¨çš„ç™Œç—‡å…ç–«ç›‘æµ‹ï¼ŒåŒ…æ‹¬æ¶æ€§ç»†èƒé˜»æ­¢å…¶å¢æ®–å¹¶ç»å†å‡‹äº¡ç»†èƒæ­»äº¡çš„ç´¯ç§¯å€¾å‘ï¼Œä»¥åŠå¯¹ CD8+ ç»†èƒæ¯’æ€§ T æ·‹å·´ç»†èƒ ï¼ˆCTLï¼‰ã€è‡ªç„¶æ€ä¼¤ ï¼ˆNKï¼‰ ç»†èƒçš„å¹¿æ³›å…ç–«åˆºæ¿€ä½œç”¨ï¼Œ æ ‘çªçŠ¶ç»†èƒ ï¼ˆDCï¼‰ å’Œè‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒ ï¼ˆTAMï¼‰ã€‚ç›¸åï¼Œå¾®å¼±ã€æƒ°æ€§å’Œæœ€ç»ˆæ— æ³•è§£å†³çš„ I å‹å¹²æ‰°ç´ ååº”å®é™…ä¸Šä¿ƒè¿›äº†è‚¿ç˜¤è¿›å±•ï¼Œä¸ä»…é€šè¿‡ä¿ƒè¿›æ¶æ€§ç»†èƒçš„å¹²æ€§ï¼ˆè¿™ä¸è½¬ç§»æ€§æ’­æ•£å’Œæ²»ç–—è€è¯æ€§å¢åŠ æœ‰å…³ï¼‰ï¼Œè€Œä¸”è¿˜æœ‰åˆ©äºå»ºç«‹é«˜åº¦å…ç–«æŠ‘åˆ¶çš„æ·‹å·´å’Œé«“ç³»è‚¿ç˜¤å¾®ç¯å¢ƒã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬å¯¹ I å‹å¹²æ‰°ç´ ä¿¡å·ä¼ å¯¼å¯¹ç™Œç—‡è¿›å±•å’Œæ²»ç–—ååº”çš„èƒŒæ™¯ä¾èµ–æ€§å½±å“è¿›è¡Œ<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1983991676504023040/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>Domvanalimab è”åˆ zimberelimab åœ¨ä¸Šå°¿è·¯ç™Œç—‡ä¸­æ˜¾ç¤ºå‡ºå‰æ™¯</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext:<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1984449727660990464/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>é‡æ–°æ€è€ƒç°ä»£è‚¿ç˜¤å­¦è¯•éªŒä¸­çš„ç»ˆç‚¹â€”â€”è¶…è¶Š P å€¼ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext:<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1984287895235239936/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>é‡æ–°æ€è€ƒç°ä»£è‚¿ç˜¤å­¦è¯•éªŒä¸­çš„ç»ˆç‚¹â€”â€”è¶…è¶Š P å€¼ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext:<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1984287899710562304/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>RANKL æŠ—ä½“ç‹„è¯ºå¡éº¦åœ¨ä¸¤ç»„å¤å‘/éš¾æ²»æ€§éª¨è‚‰ç˜¤æ‚£è€…ä¸­çš„ 2 æœŸè¯•éªŒï¼Œå„¿ç«¥è‚¿ç˜¤å­¦ç»„ ï¼ˆCOGï¼‰ çš„æŠ¥å‘Š</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: èƒŒæ™¯ï¼šå°é¼ æ¨¡å‹è¯æ˜äº† RANK åŠå…¶é…ä½“ RANKL åœ¨éª¨è‚‰ç˜¤ä¸­çš„ä½œç”¨ã€‚è¿™é¡¹å•è‡‚å¼€æ”¾æ ‡ç­¾ 2 æœŸè¯•éªŒçš„ä¸»è¦ç›®çš„æ˜¯ç¡®å®šç›¸å¯¹äºä»å†å² COG ä¸´åºŠè¯•éªŒæ•°æ®å¾—å‡ºçš„åŸºå‡†ï¼Œç‹„è¯ºå¡éº¦ï¼ˆä¸€ç§ RANKL å•å…‹éš†æŠ—ä½“ï¼‰æ˜¯å¦èƒ½æ”¹å–„å¤å‘æ€§éª¨è‚‰ç˜¤çš„ç–¾ç—…æ§åˆ¶ã€‚æ‚£è€…å’Œæ–¹æ³•ï¼š11-49 å²ä¸”æ‚£æœ‰å¯æµ‹é‡ç–¾ç—…çš„éª¨éª¼æˆç†Ÿæ‚£è€…ç¬¦åˆé˜Ÿåˆ— 1 çš„æ¡ä»¶ï¼Œæˆ–æ‰€æœ‰ç–¾ç—…éƒ¨ä½å®Œå…¨æ‰‹æœ¯åˆ‡é™¤çš„æ‚£è€…ç¬¦åˆé˜Ÿåˆ— 2 çš„æ¡ä»¶ã€‚æ‚£è€…æ¯ 4 å‘¨çš®ä¸‹æ³¨å°„ç‹„è¯ºå¡éº¦ 120 mgï¼Œå¹¶è¡¥å……é’™å’Œç»´ç”Ÿç´  Dã€‚é˜Ÿåˆ— 1 çš„ä¸»è¦ç»ˆç‚¹æ˜¯ RECIST ååº”å’Œ 4 ä¸ªæœˆçš„æ— äº‹ä»¶çŠ¶æ€ï¼Œé˜Ÿåˆ— 2 çš„ 12 ä¸ªæœˆæ— äº‹ä»¶çŠ¶æ€ã€‚æ¯’æ€§ã€è¯ä»£åŠ¨åŠ›å­¦å’Œè¯æ•ˆå­¦æ•ˆåº”æ˜¯å…¶ä»–ç»ˆç‚¹ã€‚ç»“æœï¼šé˜Ÿåˆ— 1 ä¸­çš„ 15 åæ‚£è€…å’Œé˜Ÿåˆ— 2 ä¸­çš„ 38 åæ‚£è€…ç¬¦åˆä¸»è¦ç»ˆç‚¹çš„æ¡ä»¶å¹¶å¯è¯„ä¼°ã€‚15 åé˜Ÿåˆ— 1 æ‚£è€…ä¸­çš„ä¸€ååœ¨ 4 ä¸ªæœˆæ—¶ä¿æŒæ— äº‹ä»¶ã€‚æ²¡æœ‰å®¢è§‚çš„å›åº”ã€‚38 åé˜Ÿåˆ— 2 æ‚£è€…ä¸­æœ‰ 10 ååœ¨ 12 ä¸ªæœˆæ—¶æ— äº‹<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1983669132093845504/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>å¾ªç¯è‚¿ç˜¤ DNA æ°´å¹³å¯¹å‚åŠ  plasmaMATCH è¯•éªŒçš„æ™šæœŸä¹³è…ºç™Œæ‚£è€…çš„é¢„åå’Œé¢„æµ‹å½±å“</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç›®çš„ï¼šå¾ªç¯è‚¿ç˜¤ DNA ï¼ˆctDNAï¼‰ åŠ¨æ€æ°´å¹³å¯ä»¥è¯†åˆ«å¯¹æ²»ç–—æœ‰ååº”çš„æ‚£è€…ã€‚æˆ‘ä»¬åœ¨ plasmaMATCH è¯•éªŒä¸­è¯„ä¼°äº†æ™šæœŸä¹³è…ºç™Œæ‚£è€…çš„ ctDNA åŸºçº¿æ°´å¹³å’Œæ²»ç–—åŠ¨æ€ï¼Œé‡‡ç”¨çªå˜é¶å‘æ²»ç–—ï¼ˆé˜Ÿåˆ— A-Dï¼‰å’Œä¸‰é˜´æ€§ä¹³è…ºç™Œ ï¼ˆTNBCï¼‰ è”åˆä½¿ç”¨å¥¥æ‹‰å¸•å°¼å’Œ ceralasertibï¼ˆé˜Ÿåˆ— Eï¼‰ã€‚å®éªŒè®¾è®¡ï¼šåœ¨åŸºçº¿ï¼ˆC1D1ï¼‰å’Œæ²»ç–—å‰çš„ç¬¬ 2 å¤©ï¼ˆC2D1ï¼‰é‡‡é›†è¡€æ ·ã€‚ä½¿ç”¨çº é”™çš„é¶å‘ç»„åˆï¼ˆGuardant360/GuardantOMNIï¼‰å¯¹æ ·å“è¿›è¡Œæµ‹åºã€‚å¾ªç¯ DNA æ¯”å€¼ï¼ˆCDRï¼‰è®¡ç®—ä¸º C2D1/C1D1 çš„æ¯”å€¼ã€‚CDR å’ŒåŸºçº¿ ctDNA æ°´å¹³ä¸æ— è¿›å±•ç”Ÿå­˜æœŸ ï¼ˆPFSï¼‰ å’Œç¡®è®¤å®¢è§‚ç¼“è§£ç‡ ï¼ˆORRï¼‰ ç›¸å…³ã€‚ç»“æœï¼š167 åæ‚£è€…å…·æœ‰å¯è¯„ä¼°çš„ C1D1-C2D1 ctDNA ç»“æœã€‚é˜Ÿåˆ— E çš„åŸºçº¿ ctDNA æ°´å¹³ä¸ååº”ä¹‹é—´å­˜åœ¨å¾ˆå¼ºçš„å…³è”;åŸºçº¿æ°´å¹³ä½ä¸ PFS è¾ƒé•¿ï¼ˆHR 0.33ï¼Œp=0.001ï¼‰å’Œè¾ƒé«˜çš„<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1983669139932999680/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>11.</strong> <strong>å§‹ç»ˆéµå®ˆèº«ä½“æ´»åŠ¨æŒ‡å—å’Œæ¶ˆåŒ–ç³»ç»Ÿç™Œç—‡é£é™©å’Œæ­»äº¡ç‡</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: é‡è¦æ€§è¶Šæ¥è¶Šå¤šçš„è¯æ®è¡¨æ˜ï¼Œä½“è‚²é”»ç‚¼å¯ä»¥é¢„é˜²æ¶ˆåŒ–ç³»ç»Ÿç™Œç—‡ ï¼ˆDSCï¼‰ã€‚ç„¶è€Œï¼ŒæŒç»­è¾¾åˆ°èº«ä½“æ´»åŠ¨æŒ‡å—ï¼ˆâ‰¥7.5 ä»£è°¢å½“é‡ä»»åŠ¡ï¼ˆMETï¼‰å°æ—¶/å‘¨ï¼‰æ˜¯å¦ä¸è¾ƒä½çš„ DSC é£é™©ç›¸å…³ï¼Œæˆ–è€…æ˜¯å¦éœ€è¦æ›´é«˜çš„æ°´å¹³ï¼Œç›®å‰å°šä¸æ¸…æ¥šã€‚ç›®çš„ æ¢è®¨ä½“åŠ›æ´»åŠ¨ä¸ DSC é£é™©å’Œæ­»äº¡ç‡çš„å…³ç³»ï¼Œé‡ç‚¹å…³æ³¨é•¿æœŸæ‰§è¡Œæ¨èæ°´å¹³çš„æœ€ä½³é‡å’Œé•¿æœŸä¸€è‡´æ€§ã€‚è®¾è®¡ã€è®¾ç½®å’Œå‚ä¸è€… è¿™é¡¹åŸºäºäººç¾¤çš„é˜Ÿåˆ—ç ”ç©¶åŒ…æ‹¬æ¥è‡ª 3 ä¸ªå¤§å‹ç¾å›½å‰ç»æ€§é˜Ÿåˆ—çš„æ•°æ®ï¼šå«ç”Ÿä¸“ä¸šäººå‘˜éšè®¿ç ”ç©¶ï¼Œ1988-2020 å¹´;æŠ¤å£«å¥åº·ç ”ç©¶ï¼Œ1988-2021 å¹´;å’ŒæŠ¤å£«å¥åº·ç ”ç©¶ IIï¼Œ1991-2021 å¹´ã€‚æ•°æ®åˆ†æäº 2024 å¹´ 10 æœˆè‡³ 2025 å¹´ 5 æœˆæœŸé—´è¿›è¡Œã€‚å‚ä¸è€…æ˜¯åŸºçº¿æ—¶æ²¡æœ‰ç™Œç—‡å’Œå¿ƒè¡€ç®¡ç–¾ç—…çš„ç”·æ€§å’Œå¥³æ€§ã€‚æš´éœ² ä½¿ç”¨ä¸¤å¹´ä¸€æ¬¡çš„ç»è¿‡éªŒè¯çš„é—®å·è¯„ä¼°ä¼‘é—²æ—¶é—´èº«ä½“æ´»åŠ¨çš„æ€»æ°´å¹³ï¼Œå¹¶ä»¥æ¯å‘¨ MET å°æ—¶æ•°è¡¨ç¤ºã€‚ä¸€è‡´æ€§è®¡ç®—ä¸ºè¾¾åˆ°æ¨èæ°´å¹³ï¼ˆâ‰¥7.5 MET å°æ—¶/å‘¨ï¼‰çš„éšè®¿å¹´æ•°ç™¾åˆ†æ¯”ã€‚ä¸»è¦ç»“å±€å’Œæªæ–½<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1984047236037386240/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>12.</strong> <strong>å¾®å«æ˜Ÿç¨³å®šç»“ç›´è‚ ç™Œé¶å‘æ²»ç–—åè·å¾—æ€§é«˜è‚¿ç˜¤çªå˜è´Ÿè·å’Œå…ç–«æ²»ç–—æ´»æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç›®çš„ï¼šä¸å¾®å«æ˜Ÿä¸ç¨³å®šæ€§é«˜ ï¼ˆMSI-Hï¼‰ CRC ç›¸æ¯”ï¼Œå¾®å«æ˜Ÿç¨³å®š ï¼ˆMSSï¼‰ ç»“ç›´è‚ ç™Œ ï¼ˆCRCï¼‰ çªå˜å¾ˆå°‘ï¼Œå¹¶ä¸”å¯¹å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­ ï¼ˆICBï¼‰ ä¸æ•æ„Ÿã€‚ç”¨é¶å‘è¯ç‰©æ²»ç–—çš„ CRC åœ¨è¿›å±•è¿‡ç¨‹ä¸­é€šå¸¸ä¼šè·å¾—å¤§é‡åŸºå› ç»„æ”¹å˜ã€‚æˆ‘ä»¬è¯¢é—®é¶å‘æ²»ç–—æ˜¯å¦å¯ç”¨äºåœ¨ MSS CRC ä¸­äº§ç”Ÿé«˜è‚¿ç˜¤çªå˜è´Ÿè· ï¼ˆTMBï¼‰ å¹¶ä½¿è¿™äº›è‚¿ç˜¤å¯¹ ICB æ•æ„Ÿã€‚æ‚£è€…å’Œæ–¹æ³•ï¼šåœ¨æ¥å—é¶å‘æ²»ç–—çš„ MSS è½¬ç§»æ€§ CRC æ‚£è€…ä¸­ï¼Œæˆ‘ä»¬è¯„ä¼°äº†è‚¿ç˜¤å‘å±•ä¸ºé«˜ TMB çš„æ‚£è€…çš„åŸºçº¿å’Œè¿›å±• TMB ä»¥åŠå¯¹ ICB çš„ååº”ã€‚æˆ‘ä»¬ç¡®å®šäº†åœ¨è·å¾—æ€§é«˜ TMB ç—…ä¾‹ä¸­ä¸ç´§æ€¥åŸºå› ç»„æ”¹å˜ç›¸å…³çš„æ”¹å˜ç±»å‹ã€çªå˜ç‰¹å¾ã€æ–°æŠ—åŸæ€§å’Œå…‹éš†æ€§ã€‚ç»“æœï¼š26 ä¾‹ç—…ä¾‹ä¸­ï¼Œ9 ä¾‹è¿›å±•æ—¶ TMB å‡é«˜ã€‚å…¶ä¸­ä¸‰åæ‚£è€…æ¥å—äº† ICBï¼Œä½†å‡æ— ååº”ã€‚åœ¨ TMB é«˜ç—…ä¾‹ä¸­ï¼Œæˆ‘ä»¬æ²¡æœ‰å‘ç°è‚¿ç˜¤æµ¸æ¶¦æ·‹å·´ç»†èƒçš„è¯±å¯¼æˆ–ç¨‹åºæ€§æ­»äº¡é…ä½“ 1 è¡¨è¾¾ã€‚è·å¾—æ€§åŸºå› ç»„æ”¹å˜ä¸»è¦ç”±å•æ ¸è‹·é…¸å˜å¼‚ç»„æˆï¼Œå¯Œé›†äº†å•ç¢±åŸºå–ä»£<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1984017175993294848/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>13.</strong> <strong>RAS-GTP æŠ‘åˆ¶å…‹æœéå°ç»†èƒè‚ºç™Œä¸­ç”±è‡´ç™Œå’Œé‡ç”Ÿå‹ RAS æ¿€æ´»ä»‹å¯¼çš„å¯¹ KRASG12C æŠ‘åˆ¶å‰‚çš„è·å¾—æ€§è€è¯æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè€è¯<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ä¸ KRAS çš„éæ´»æ€§ GDP ç»“åˆçŠ¶æ€ç»“åˆçš„å°åˆ†å­ KRASG12C ï¼ˆOFFï¼‰ æŠ‘åˆ¶å‰‚å·²åœ¨ KRASG12C çªå˜è‚¿ç˜¤æ‚£è€…ä¸­æ˜¾ç¤ºå‡ºç–—æ•ˆï¼Œä½†ç”±äºå‡ºç°æ²»ç–—è€è¯æ€§ï¼Œååº”å¾€å¾€æ˜¯çŸ­æš‚çš„ã€‚æœ€è¿‘ï¼Œæè¿°äº†ä¸ RAS çš„æ´»æ€§ GTP ç»“åˆçŠ¶æ€ç»“åˆçš„ RASï¼ˆONï¼‰ G12C é€‰æ‹©æ€§æŠ‘åˆ¶å‰‚ï¼Œå¹¶ä¸” elironrasib æ­£åœ¨å¤šé¡¹ä¸´åºŠè¯•éªŒä¸­è¿›è¡Œè¯„ä¼°ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬ç”Ÿæˆäº†è€è¯ç»†èƒç³»å’Œæ‚£è€…æ¥æºçš„å¼‚ç§ç§»æ¤æ¨¡å‹ï¼Œä»¥ KRASG12Cï¼ˆOFFï¼‰å’Œ RASï¼ˆONï¼‰G12C é€‰æ‹©æ€§æŠ‘åˆ¶å‰‚ï¼Œå¹¶ä½¿ç”¨å¤šç»„å­¦ç­–ç•¥è¯¢é—®è€è¯æœºåˆ¶ï¼Œè¯¥ç­–ç•¥åŒ…æ‹¬ç£·é…¸è›‹ç™½è´¨ç»„å­¦ã€å…¨å¤–æ˜¾å­ç»„æµ‹åºå’Œ RNA æµ‹åºï¼Œç»“åˆä½¿ç”¨å°åˆ†å­å’Œ CRISPR ç­›é€‰çš„åŠŸèƒ½æµ‹è¯•ï¼Œä»¥åŠæ­£åœ¨ä¸´åºŠè¯•éªŒä¸­è¯„ä¼°çš„ RASï¼ˆONï¼‰æŠ‘åˆ¶å‰‚ã€‚ä¸¤ç§æ¨¡å‹é€šè¿‡ KRASG12C åŸºå› æ‰©å¢æˆ– NRASG13R çªå˜é‡æ–°æ¿€æ´»äº† RAS ä¿¡å·ä¼ å¯¼ï¼Œå¹¶ä¸”å®¹æ˜“å—åˆ° RASï¼ˆONï¼‰G12C é€‰æ‹©æ€§å’Œ RASï¼ˆONï¼‰å¤šé€‰æ‹©æ€§æŠ‘åˆ¶å‰‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1984017167432720384/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>14.</strong> <strong>é¶å‘ CDK12/13 å¯é©±åŠ¨æœ‰ä¸åˆ†è£‚åœæ»ä»¥å…‹æœå¯¹ KRASG12C æŠ‘åˆ¶å‰‚çš„è€è¯æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè€è¯<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: è·å¾—æ€§è€è¯çš„å‘ä½œé™åˆ¶äº† KRASG12C æŠ‘åˆ¶å‰‚åœ¨è‚ºç™Œæ‚£è€…ä¸­çš„ç–—æ•ˆã€‚ä¸´åºŠå‰æ¨¡å‹ç³»ç»Ÿçš„å®éªŒå’Œå¯¹æ¥å—è¿™äº›æŠ‘åˆ¶å‰‚æ²»ç–—çš„æ‚£è€…çš„å›é¡¾æ€§åˆ†æéƒ½è¡¨æ˜ï¼ŒDNA ä¿®å¤é€”å¾„å’Œ G2/M æ¿€é…¶çš„æ¿€æ´»åœ¨å¯¹ KRASG12C æŠ‘åˆ¶å‰‚å…·æœ‰è·å¾—æ€§è€è¯æ€§çš„è‚ºç™Œä¸­å¾ˆå¸¸è§ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬åœ¨å‡ ç§å¯¹ sotorasib å…·æœ‰è·å¾—æ€§è€è¯æ€§çš„ KRASG12C çªå˜ç»†èƒç³»ä¸­å‘ç°äº† CDK12/13 é€‰æ‹©æ€§æŠ‘åˆ¶å‰‚ SR-4835 çš„å…±åŒè„†å¼±æ€§ã€‚åœ¨æˆå¯¹çš„ KRASG12C çªå˜äº²æœ¬å’Œ sotorasib è€è¯ç»†èƒç³»ä¸­ï¼ŒCDK12/13 æŠ‘åˆ¶æŠ‘åˆ¶ DNA ä¿®å¤åŸºå› è¡¨è¾¾å¹¶è¯±å¯¼æœ‰ä¸åˆ†è£‚åœæ»ï¼Œè¿™åœ¨ sotorasib è€è¯ç»†èƒä¸­å› æœªèƒ½æ¿€æ´» G2/M æ£€æŸ¥ç‚¹å’ŒæŠ‘åˆ¶ TP73 çš„è‡´ç™Œäºšå‹è€ŒåŠ å‰§ã€‚ä¸ sotorasib å’Œ SR-4835 è”åˆæ²»ç–—äº§ç”Ÿäº†ç´¯åŠ ååº”ï¼Œå¹¶æŠ‘åˆ¶äº†å¯¹ä»»ä¸€æŠ‘åˆ¶å‰‚çš„è·å¾—æ€§è€è¯çš„å‘å±•ã€‚æŠ‘åˆ¶å‰‚ç»„åˆå¯¼è‡´åŠ æ€§ G1 å’Œ G2/M åœæ»ï¼Œå¹¶ä¸”æ–°å…´è€è¯ç»†èƒç¾¤å¯¹<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1984017182326693888/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡ (8æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨8æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>åˆ©ç”¨æœ‰ç•Œè°ƒå’Œå¹³å‡å€¼è¿‘ä¼¼è¯æ®ï¼ˆä»¥åŠå…·æœ‰å·²çŸ¥ä½“ç§¯çš„HPDåŒºåŸŸï¼‰</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€Visiumã€genomeã€genomicsã€proteomeã€proteomicsã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šFollowing a suggestion by Christian Hennig at JSM 2024, I started working with my PhD student Dana Naderi on a detailed assessment of the method we proposed in 2009 with Darren Wraith for evidence approximation. (The method was briefly mentioned in a Physical Review paper and also briefly illustrated in our 2010 San ... Continue reading: Approximating evidence via bounded harmonic means (and HPD regions with known volumes)<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/10/approximating-evidence-via-bounded-harmonic-means-and-hpd-regions-with-known-volumes/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>å½“ç„¶ï¼Œè¦æ„å»ºå¯å¤ç°çš„æ•°æ®ç§‘å­¦æµç¨‹ï¼Œæ€»å¾—æœ‰äººç¼–å†™å‘½ä»¤å¼ä»£ç ã€‚ä½†è¿™ä¸ªäººä¸ä¸€å®šæ˜¯ä½ ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šscRNAã€scDNAã€scATACã€spatialã€Seuratã€Scanpyã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šLast time I quickly introduced my latest package, {rixpress}, but I think that to really understand what {rixpress} brings to the table, one needs to solve the same problem without it. And incidentally, I think that this exercise also show... Continue reading: Of course, someone has to write imperative code to build reproducible data science pipelines. It doesnâ€™t have to be you.<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/10/of-course-someone-has-to-write-imperative-code-to-build-reproducible-data-science-pipelines-it-doesnt-have-to-be-you/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>ä½¿ç”¨ JavaScript API ç®€åŒ– shinytest2 ä¸­å¤æ‚ç»„ä»¶çš„äº¤äº’</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šscDNAã€genomeã€genomicsã€epigenetic<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šWhen shinytest2's <code>set_inputs()</code> won't work, leverage widget APIs directly. Learn to write cleaner, faster and more robust tests using JavaScript APIs. Continue reading: Simplifying Interactions with Complex Widgets in shinytest2 Using JavaScript APIs<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/10/simplifying-interactions-with-complex-widgets-in-shinytest2-using-javascript-apis/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>é©¾é©­æ³¢åŠ¨ï¼šåˆ©ç”¨ H2O AutoML å¯¹ STOXX 600 æŒ‡æ•°è¿›è¡Œé«˜æ€§èƒ½é¢„æµ‹</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šHi-Cã€Visium<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šForecasting financial markets, such as the STOXX Europe 600 Index, presents a classic Machine Learning challenge: the data is inherently noisy, non-stationary, and highly susceptible to sudden market events. To tackle this, we turn to Automated Machine Learning (AutoML)â€”specifically the powerful, scalable framework provided by H2O.ai and integrated ... Continue reading: Taming Volatility: High-Performance Forecasting of the STOXX 600 with H2O AutoML<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/11/taming-volatility-high-performance-forecasting-of-the-stoxx-600-with-h2o-automl/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>2025å¹´9æœˆæ’åå‰40çš„æ–°CRANè½¯ä»¶åŒ…</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šscRNAã€R package<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šComputational Methods fastfocal v0.1.3: Provides a fast moving-window (â€œfocalâ€) and buffer-based extraction for raster data using the terra package. Automatically selects between a C++ backend and a Fast Fourier Transform (FFT) backend depend... Continue reading: September 2025 Top 40 New CRAN Packages<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/10/september-2025-top-40-new-cran-packages/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>ä¸€äº›æ— ç”¨å´æœ‰ç”¨çš„ R å‡½æ•°â€”â€”R éœ€æ±‚æ— ç”¨é‡‘å­—å¡”</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumor<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šWhat motivates human behaviour can be captured in the Maslowâ€™s hierarchy of needs (source: Wiki). Maslow and psychologists have articulated these needs in a form of a Pyramid, and ever since the concept had been widely adopted (also criticised), andâ€¦Read more â€º Continue reading: Little useless-useful R functions â€“ Useless Pyramid of R needs<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/11/little-useless-useful-r-functions-useless-pyramid-of-r-needs/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>ä»€ä¹ˆæ˜¯åŸºå°¼ç³»æ•°ï¼Ÿå¦‚ä½•è®¡ç®—åŸºå°¼ç³»æ•°ï¼Ÿ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šscDNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šIf this post is useful to you I kindly ask a minimal donation on Buy Me a Coffee. It shall be used to continue my Open Source efforts. You can send me questions for the blog using this form and subscribe to receive an email when there is a new ... Continue reading: Â¿QuÃ© es el Ãndice de Gini y cÃ³mo calcularlo?<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/10/que-es-el-indice-de-gini-y-como-calcularlo/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>é€šè¿‡ Jumping Rivers åŸ¹è®­æå‡æ‚¨çš„æ•°æ®æŠ€èƒ½</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šVisium<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šIn todayâ€™s data-driven world, strong analytical and programming skills are essential for success. Whether youâ€™re just starting your data journey or looking to expand your expertise, Jumping Rivers offers training that combines real-world experien... Continue reading: Elevate Your Data Skills with Jumping Rivers Training<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/10/elevate-your-data-skills-with-jumping-rivers-training/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (10æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>ç”Ÿç‰©ä¿¡æ¯å­¦è§†è§’ä¸‹çš„è½¬å½•ç»„å­¦ï¼šæ‰¹é‡å’Œå•ç»†èƒRNAæµ‹åºåˆ†æçš„å…¨é¢ç»¼è¿°</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€sequencingã€RNA-seqã€RNAseqã€ATAC-seqã€Hi-Cã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€transcriptomeã€transcriptomicsã€bioinformaticsã€R packageã€Scanpyã€pathwayã€resistance<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers from the Yucatan Scientific Research Center have published an insightful review examining how advances in RNA sequencing (RNA-seq) technologies are revolutionizing the field of transcriptomics, the study of all RNA molecules produced in a cell. The transcriptome provides a detailed snapshot of cellular activity, showing which genes are active, how strongly they are ...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/bioinformatics-perspectives-on-transcriptomics-a-comprehensive-review-of-bulk-and-single-cell-rna-sequencing-analyses/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>MultiGATEâ€”â€”åŸºäºå›¾è¡¨ç¤ºå­¦ä¹ çš„ç©ºé—´å¤šç»„å­¦æ•°æ®æ•´åˆåˆ†æå’Œè°ƒæ§æ¨æ–­</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€Seuratã€clusteringã€depmap<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers from the Chinese University of Hong Kong have introduced an innovative approach called MultiGATE, designed to integrate complex spatial multi-omics data. Spatial multi-omics combines information about where specific molecules are located in tissues with what genes or proteins they represent. By linking transcriptomics (RNA sequencing data) with other molecular features like proteins and ...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/multigate-integrative-analysis-and-regulatory-inference-in-spatial-multi-omics-data-via-graph-representation-learning/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>RNAæµ‹åºæ­ç¤ºäº†Tç»†èƒéšå¹´é¾„å˜åŒ–è€Œå‘ç”Ÿçš„æ”¹å˜ï¼Œè¿™äº›æ”¹å˜ä¼šå‰Šå¼±ç–«è‹—ååº”ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€sequencingã€RNAseqã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€Seuratã€histoneã€resistance<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers used single-cell RNA sequencing to reveal how aging alters T cell function, explaining weaker vaccine responses in older adults and guiding future vaccine innovations...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/how-rna-sequencing-reveals-age-related-changes-in-t-cells-that-weaken-vaccine-responses/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>å•ç»†èƒå‰ªæ¥ä¼°è®¡â€”â€”ä»¥å•ç»†èƒåˆ†è¾¨ç‡è§£æå‰ªæ¥å¼‚è´¨æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€Hi-Cã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€spatialã€Scanpyã€epigeneticã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers developed SCSES, a computational tool that enhances RNA sequencing data by accurately detecting alternative splicing and revealing hidden cellular diversity...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/single-cell-splicing-estimation-deciphering-splicing-heterogeneity-at-single-cell-resolution/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>sysVIâ€”â€”æ•´åˆå…·æœ‰æ˜¾è‘—æ‰¹æ¬¡æ•ˆåº”çš„å•ç»†èƒRNAæµ‹åºæ•°æ®é›†</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€RNAseqã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€resistance<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers at Helmholtz Munich developed sysVI, a machine learning method that improves integration of RNA sequencing data across diverse systems while preserving vital...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/sysvi-integrating-single-cell-rna-seq-datasets-with-substantial-batch-effects/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>CytoTRACE 2 â€“ æ”¹è¿›çš„å•ç»†èƒå‘è‚²æ½œèƒ½é‡å»º</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcarcinomaã€single.cellã€single-cellã€scDNAã€spatialã€proteomeã€depmap<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers at Stanford University, have introduced a powerful new computational framework called CytoTRACE 2 that improves our ability to predict how individual cells develop and specialize. This innovation represents a major advance in single-cell biology and data-driven research. Understanding how cells transition from one type to another, such as how stem cells mature into ...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/cytotrace-2-improved-reconstruction-of-single-cell-developmental-potential/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>OpenPedCan æ‰©å¤§äº†å…¨çƒç ”ç©¶äººå‘˜è·å–å„¿ç§‘ç™Œç—‡æ•°æ®çš„é€”å¾„ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€scRNAã€scDNAã€scATACã€spatial<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šThe OpenPedCan Project harmonizes genomic and clinical data from over 6,000 pediatric tumors across 100 cancer types, creating an open-access resource to advance collaboration and accelerate childhood cancer research. Modern cancer breakthroughs depend on collaboration and open data. The Open Pediatric Cancer (OpenPedCan) Project, published last month in GigaScience, is opening new doors for ...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/openpedcan-expands-access-to-pediatric-cancer-data-for-researchers-worldwide/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>åœ¨å•ä¸ªæ¤ç‰©ç»†èƒä¸­å°†åŸºå› è¡¨è¾¾ä¸ä»£è°¢ç‰©äº§ç”Ÿç›¸åŒ¹é…</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsingle.cellã€genomeã€genomicsã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šA pioneering method enables simultaneous RNA and metabolite analysis To the point Gene activity and plant metabolites analyzed together in the same plant cell for the first time: Researchers have combined two techniques, single-cell RNA sequencing (scRNA-seq) and single-cell mass spectrometry (scMS), to measure gene expression and the metabolite profile in the same cell. A ...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/matching-gene-expression-to-metabolite-production-in-single-plant-cells/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>P-body-seq å¯ä»¥å¯¹ P ä½“æˆåˆ†è¿›è¡Œå…¨é¢åˆ†æã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šHi-C<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šA team led by researchers at Baylor College of Medicine has uncovered a surprising mechanism that helps determine how stem cells decide what type of cell they will become. Their work focuses on RNA condensates, tiny, droplet-like structures inside cells that organize and store RNA molecules. One type of RNA condensate, known as a ...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/p-body-seq-permits-comprehensive-profiling-of-p-body-contents/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>2025 å¹´å•ç»†èƒæ–¹æ³•æ–°æŒ‡å—</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsingle.cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šNew guide for emerging single cell methods: Methyl-Seq, CRISPR-Cas9 Screening, Gene Expression, ATAC-Seq, Multiomics, and more! Single cell sequencing is changing rapidly, with new methods that enable as many as 2.6 million cells to be sequenced at once at 62% lower cost*. Download the NEW Single Cell Methods Guide to learn about emerging techniques ...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/new-single-cell-methods-guide-2025/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>scRNA</td>
<td>36</td>
</tr>
<tr>
<td>genome</td>
<td>34</td>
</tr>
<tr>
<td>scDNA</td>
<td>32</td>
</tr>
<tr>
<td>scATAC</td>
<td>32</td>
</tr>
<tr>
<td>Seurat</td>
<td>32</td>
</tr>
<tr>
<td>cancer</td>
<td>31</td>
</tr>
<tr>
<td>spatial</td>
<td>28</td>
</tr>
<tr>
<td>genomics</td>
<td>26</td>
</tr>
<tr>
<td>tumor</td>
<td>24</td>
</tr>
<tr>
<td>histone</td>
<td>23</td>
</tr>
<tr>
<td>proteome</td>
<td>18</td>
</tr>
<tr>
<td>resistance</td>
<td>16</td>
</tr>
<tr>
<td>RNAseq</td>
<td>15</td>
</tr>
<tr>
<td>single.cell</td>
<td>12</td>
</tr>
<tr>
<td>Hi-C</td>
<td>12</td>
</tr>
<tr>
<td>Scanpy</td>
<td>12</td>
</tr>
<tr>
<td>depmap</td>
<td>12</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>11</td>
</tr>
<tr>
<td>epigenetic</td>
<td>11</td>
</tr>
<tr>
<td>transcriptome</td>
<td>10</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (7æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309506" target="_blank" rel="noopener noreferrer">GSE309506 åˆ©é²å”‘å¯¹æ‚£è€…æ¥æºè¿åŠ¨ç¥ç»å…ƒçš„å¥åº·è¿›è¡Œè¯ç†å­¦æŒ½æ•‘</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301153" target="_blank" rel="noopener noreferrer">GSE301153 ç”Ÿé…®é¥®é£Ÿå¯æ”¹å–„ APOE4 é˜¿å°”èŒ¨æµ·é»˜ç—…å°é¼ æ¨¡å‹ä¸­é›Œæ€§çš„è®°å¿†åŠ›ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275333" target="_blank" rel="noopener noreferrer">GSE275333 MeCP2 ä¸è¶…å»¶ä¼¸å¤åˆç‰©ç›¸äº’ä½œç”¨ä»¥è°ƒæ§è½¬å½•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300606" target="_blank" rel="noopener noreferrer">GSE300606 MNX1 é€šè¿‡æŠ‘åˆ¶ PERCC1 æ¥é˜»æ­¢äºº Î² ç»†èƒä¸­ç”Ÿé•¿æŠ‘ç´ çš„è¡¨è¾¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281029" target="_blank" rel="noopener noreferrer">GSE281029 ä¿å®ˆçš„çƒ­æ¿€å› å­é€šè¿‡ä¸åŒçš„æœºåˆ¶æ§åˆ¶å¤§éº¦çš„çƒ­èƒè¿«è®°å¿†</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271342" target="_blank" rel="noopener noreferrer">GSE271342 ç»„è›‹ç™½2Bå•æ³›ç´ åŒ–è°ƒæ§RNAèšåˆé…¶IIè½¬å½•çš„å»¶ä¼¸-ç»ˆæ­¢è½¬æ¢</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE261266" target="_blank" rel="noopener noreferrer">GSE261266 TPOåˆºæ¿€ä»‹å¯¼iKMT2A-MLLT3 HSPCçš„åŸºå› è¡¨è¾¾</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-03 07:44</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>